WO2001012833A2 - Process for the biological production of 1,3-propanediol - Google Patents
Process for the biological production of 1,3-propanediol Download PDFInfo
- Publication number
- WO2001012833A2 WO2001012833A2 PCT/US2000/022874 US0022874W WO0112833A2 WO 2001012833 A2 WO2001012833 A2 WO 2001012833A2 US 0022874 W US0022874 W US 0022874W WO 0112833 A2 WO0112833 A2 WO 0112833A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- propanediol
- glycerol
- gene encoding
- activity
- polypeptide
- Prior art date
Links
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 title claims abstract description 223
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 title claims abstract description 215
- 229920000166 polytrimethylene carbonate Polymers 0.000 title claims abstract description 214
- 238000000034 method Methods 0.000 title claims abstract description 106
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 83
- 230000008569 process Effects 0.000 title claims abstract description 47
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 341
- 241000588724 Escherichia coli Species 0.000 claims abstract description 131
- 244000005700 microbiome Species 0.000 claims abstract description 84
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 81
- 108090001042 Hydro-Lyases Proteins 0.000 claims abstract description 77
- 102000004867 Hydro-Lyases Human genes 0.000 claims abstract description 76
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 66
- 238000006243 chemical reaction Methods 0.000 claims abstract description 62
- 101150061843 dhaT gene Proteins 0.000 claims abstract description 62
- 230000003197 catalytic effect Effects 0.000 claims abstract description 48
- 108010011958 1,3-propanediol dehydrogenase Proteins 0.000 claims abstract description 41
- 230000007420 reactivation Effects 0.000 claims abstract description 30
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 claims abstract description 22
- 101100224392 Bacillus subtilis (strain 168) dpaA gene Proteins 0.000 claims abstract description 14
- 101000743006 Lactococcus lactis subsp. cremoris UPF0177 protein in abiGi 5'region Proteins 0.000 claims abstract description 14
- 101100387236 Lactococcus lactis subsp. lactis (strain IL1403) dhaS gene Proteins 0.000 claims abstract description 6
- 101150066721 dhaR gene Proteins 0.000 claims abstract description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 416
- 229940035437 1,3-propanediol Drugs 0.000 claims description 209
- 230000000694 effects Effects 0.000 claims description 149
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 93
- 229920001184 polypeptide Polymers 0.000 claims description 92
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 92
- 239000000758 substrate Substances 0.000 claims description 63
- RXKJFZQQPQGTFL-UHFFFAOYSA-N dihydroxyacetone Chemical compound OCC(=O)CO RXKJFZQQPQGTFL-UHFFFAOYSA-N 0.000 claims description 58
- 150000007523 nucleic acids Chemical group 0.000 claims description 58
- 239000013612 plasmid Substances 0.000 claims description 57
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 34
- 230000035772 mutation Effects 0.000 claims description 34
- 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 claims description 32
- 229940120503 dihydroxyacetone Drugs 0.000 claims description 29
- 108010025885 Glycerol dehydratase Proteins 0.000 claims description 28
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 claims description 27
- 150000001413 amino acids Chemical class 0.000 claims description 25
- 239000013598 vector Substances 0.000 claims description 25
- 108700016170 Glycerol kinases Proteins 0.000 claims description 21
- 102000057621 Glycerol kinases Human genes 0.000 claims description 20
- 108010032776 glycerol-1-phosphatase Proteins 0.000 claims description 20
- 108700015934 Triose-phosphate isomerases Proteins 0.000 claims description 17
- 230000000295 complement effect Effects 0.000 claims description 17
- 241000588748 Klebsiella Species 0.000 claims description 15
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 claims description 15
- 108010065027 Propanediol Dehydratase Proteins 0.000 claims description 13
- 101100277683 Citrobacter freundii dhaB gene Proteins 0.000 claims description 12
- 241000588923 Citrobacter Species 0.000 claims description 11
- 241000193403 Clostridium Species 0.000 claims description 10
- 241000235070 Saccharomyces Species 0.000 claims description 10
- 150000004676 glycans Chemical class 0.000 claims description 10
- 150000002772 monosaccharides Chemical class 0.000 claims description 10
- 229920001542 oligosaccharide Polymers 0.000 claims description 10
- 150000002482 oligosaccharides Chemical class 0.000 claims description 10
- 229920001282 polysaccharide Polymers 0.000 claims description 10
- 239000005017 polysaccharide Substances 0.000 claims description 10
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims description 9
- -1 DARl Proteins 0.000 claims description 9
- 101150059691 GPP2 gene Proteins 0.000 claims description 9
- 241000235648 Pichia Species 0.000 claims description 9
- 238000009396 hybridization Methods 0.000 claims description 9
- 230000000415 inactivating effect Effects 0.000 claims description 9
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 241000187747 Streptomyces Species 0.000 claims description 6
- 241000588914 Enterobacter Species 0.000 claims description 5
- 241000607142 Salmonella Species 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 241000228212 Aspergillus Species 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 4
- 241000235035 Debaryomyces Species 0.000 claims description 4
- 102100030395 Glycerol-3-phosphate dehydrogenase, mitochondrial Human genes 0.000 claims description 4
- 101001009678 Homo sapiens Glycerol-3-phosphate dehydrogenase, mitochondrial Proteins 0.000 claims description 4
- 241000235649 Kluyveromyces Species 0.000 claims description 4
- 101100393312 Lactobacillus delbrueckii subsp. bulgaricus (strain ATCC 11842 / DSM 20081 / BCRC 10696 / JCM 1002 / NBRC 13953 / NCIMB 11778 / NCTC 12712 / WDCM 00102 / Lb 14) gpsA1 gene Proteins 0.000 claims description 4
- 241000589350 Methylobacter Species 0.000 claims description 4
- 241000235395 Mucor Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 241000235346 Schizosaccharomyces Species 0.000 claims description 4
- 241000235017 Zygosaccharomyces Species 0.000 claims description 4
- 101150095733 gpsA gene Proteins 0.000 claims description 4
- 241000873310 Citrobacter sp. Species 0.000 claims description 3
- 241000193464 Clostridium sp. Species 0.000 claims description 3
- 101150067026 GPD3 gene Proteins 0.000 claims description 3
- 241000588754 Klebsiella sp. Species 0.000 claims description 3
- 101100393309 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GPD2 gene Proteins 0.000 claims description 3
- 101100174613 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) TDH3 gene Proteins 0.000 claims description 3
- 101100179978 Arabidopsis thaliana IRX10 gene Proteins 0.000 claims description 2
- 101100233722 Arabidopsis thaliana IRX10L gene Proteins 0.000 claims description 2
- 101100504994 Lactococcus lactis subsp. lactis (strain IL1403) glpO gene Proteins 0.000 claims description 2
- 101150081661 glpD gene Proteins 0.000 claims description 2
- 101150020594 glpD1 gene Proteins 0.000 claims description 2
- 101150059349 gut2 gene Proteins 0.000 claims description 2
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 claims 6
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 80
- 239000008103 glucose Substances 0.000 abstract description 77
- 230000001976 improved effect Effects 0.000 abstract description 27
- 101150112014 Gapdh gene Proteins 0.000 abstract description 19
- 241000588747 Klebsiella pneumoniae Species 0.000 abstract description 18
- 101000885789 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) D-glycerol 3-phosphate phosphatase Proteins 0.000 abstract description 16
- 101000746457 Neisseria gonorrhoeae UPF0213 protein in glnA 3'region Proteins 0.000 abstract description 12
- 102000045595 Phosphoprotein Phosphatases Human genes 0.000 abstract description 7
- 230000002068 genetic effect Effects 0.000 abstract description 7
- 230000008520 organization Effects 0.000 abstract description 5
- 108020004414 DNA Proteins 0.000 description 83
- 210000004027 cell Anatomy 0.000 description 82
- 238000000855 fermentation Methods 0.000 description 81
- 230000004151 fermentation Effects 0.000 description 80
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 78
- 239000012634 fragment Substances 0.000 description 72
- 238000003752 polymerase chain reaction Methods 0.000 description 44
- 102000004190 Enzymes Human genes 0.000 description 42
- 108090000790 Enzymes Proteins 0.000 description 42
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 41
- GNGACRATGGDKBX-UHFFFAOYSA-N dihydroxyacetone phosphate Chemical compound OCC(=O)COP(O)(O)=O GNGACRATGGDKBX-UHFFFAOYSA-N 0.000 description 40
- 102000004169 proteins and genes Human genes 0.000 description 40
- 235000018102 proteins Nutrition 0.000 description 38
- 230000014509 gene expression Effects 0.000 description 37
- 239000002773 nucleotide Substances 0.000 description 37
- 125000003729 nucleotide group Chemical group 0.000 description 37
- 239000000047 product Substances 0.000 description 35
- 239000002609 medium Substances 0.000 description 33
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 33
- 239000011782 vitamin Substances 0.000 description 28
- 229940088594 vitamin Drugs 0.000 description 28
- 235000001014 amino acid Nutrition 0.000 description 27
- 239000000499 gel Substances 0.000 description 27
- 229940024606 amino acid Drugs 0.000 description 25
- 102000039446 nucleic acids Human genes 0.000 description 25
- 108020004707 nucleic acids Proteins 0.000 description 25
- 239000000523 sample Substances 0.000 description 25
- 230000009466 transformation Effects 0.000 description 25
- 235000013343 vitamin Nutrition 0.000 description 25
- 229930003231 vitamin Natural products 0.000 description 25
- 102100036669 Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Human genes 0.000 description 24
- 238000007792 addition Methods 0.000 description 24
- 150000003722 vitamin derivatives Chemical class 0.000 description 23
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 22
- 108091028043 Nucleic acid sequence Proteins 0.000 description 22
- 238000003556 assay Methods 0.000 description 21
- 230000037361 pathway Effects 0.000 description 21
- 108700026244 Open Reading Frames Proteins 0.000 description 20
- 230000012010 growth Effects 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 230000001419 dependent effect Effects 0.000 description 19
- AWUCVROLDVIAJX-GSVOUGTGSA-N sn-glycerol 3-phosphate Chemical compound OC[C@@H](O)COP(O)(O)=O AWUCVROLDVIAJX-GSVOUGTGSA-N 0.000 description 19
- 238000010276 construction Methods 0.000 description 18
- 230000037430 deletion Effects 0.000 description 18
- 238000012217 deletion Methods 0.000 description 18
- 101150033931 gldA gene Proteins 0.000 description 17
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 16
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 16
- 101100098786 Bacillus subtilis (strain 168) tapA gene Proteins 0.000 description 16
- 101100321116 Escherichia coli (strain K12) yqhD gene Proteins 0.000 description 16
- 229960005091 chloramphenicol Drugs 0.000 description 16
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 16
- 101150056064 glpK gene Proteins 0.000 description 16
- 108020004705 Codon Proteins 0.000 description 15
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 15
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 15
- 239000000284 extract Substances 0.000 description 15
- 238000010367 cloning Methods 0.000 description 14
- 239000006142 Luria-Bertani Agar Substances 0.000 description 13
- 101150032129 egsA gene Proteins 0.000 description 13
- 101150040073 glpK2 gene Proteins 0.000 description 13
- 101150080369 tpiA gene Proteins 0.000 description 13
- 230000004075 alteration Effects 0.000 description 12
- 229930027917 kanamycin Natural products 0.000 description 12
- 229960000318 kanamycin Drugs 0.000 description 12
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 12
- 229930182823 kanamycin A Natural products 0.000 description 12
- XJLXINKUBYWONI-DQQFMEOOSA-N [[(2r,3r,4r,5r)-5-(6-aminopurin-9-yl)-3-hydroxy-4-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2s,3r,4s,5s)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphate Chemical compound NC(=O)C1=CC=C[N+]([C@@H]2[C@H]([C@@H](O)[C@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-DQQFMEOOSA-N 0.000 description 11
- 229960000723 ampicillin Drugs 0.000 description 11
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 101100280051 Brucella abortus biovar 1 (strain 9-941) eryH gene Proteins 0.000 description 10
- 241000588919 Citrobacter freundii Species 0.000 description 10
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 10
- 101100235161 Mycolicibacterium smegmatis (strain ATCC 700084 / mc(2)155) lerI gene Proteins 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 239000000543 intermediate Substances 0.000 description 9
- 230000036961 partial effect Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 229930091371 Fructose Natural products 0.000 description 8
- 239000005715 Fructose Substances 0.000 description 8
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 8
- 102000004316 Oxidoreductases Human genes 0.000 description 8
- 108090000854 Oxidoreductases Proteins 0.000 description 8
- 229960003669 carbenicillin Drugs 0.000 description 8
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 8
- 239000003153 chemical reaction reagent Substances 0.000 description 8
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 230000010076 replication Effects 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 229910001868 water Inorganic materials 0.000 description 8
- 230000003833 cell viability Effects 0.000 description 7
- 239000013601 cosmid vector Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 235000000346 sugar Nutrition 0.000 description 7
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 6
- RXGJTUSBYWCRBK-UHFFFAOYSA-M 5-methylphenazinium methyl sulfate Chemical compound COS([O-])(=O)=O.C1=CC=C2[N+](C)=C(C=CC=C3)C3=NC2=C1 RXGJTUSBYWCRBK-UHFFFAOYSA-M 0.000 description 6
- 101710088194 Dehydrogenase Proteins 0.000 description 6
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 description 6
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 6
- 229940041514 candida albicans extract Drugs 0.000 description 6
- 239000003054 catalyst Substances 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 230000002759 chromosomal effect Effects 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000006872 improvement Effects 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 238000002955 isolation Methods 0.000 description 6
- 239000003550 marker Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000002503 metabolic effect Effects 0.000 description 6
- 108091033319 polynucleotide Proteins 0.000 description 6
- 102000040430 polynucleotide Human genes 0.000 description 6
- 239000002157 polynucleotide Substances 0.000 description 6
- 230000006798 recombination Effects 0.000 description 6
- 238000005215 recombination Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 108091008146 restriction endonucleases Proteins 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 239000012138 yeast extract Substances 0.000 description 6
- 101150113187 yqhD gene Proteins 0.000 description 6
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 5
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 5
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 5
- 235000011130 ammonium sulphate Nutrition 0.000 description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 230000008030 elimination Effects 0.000 description 5
- 238000003379 elimination reaction Methods 0.000 description 5
- 230000034659 glycolysis Effects 0.000 description 5
- 229910052816 inorganic phosphate Inorganic materials 0.000 description 5
- 230000010354 integration Effects 0.000 description 5
- 229910001629 magnesium chloride Inorganic materials 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 230000004048 modification Effects 0.000 description 5
- 238000012986 modification Methods 0.000 description 5
- 238000010369 molecular cloning Methods 0.000 description 5
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 229960004063 propylene glycol Drugs 0.000 description 5
- 235000013772 propylene glycol Nutrition 0.000 description 5
- 150000008163 sugars Chemical class 0.000 description 5
- 230000014616 translation Effects 0.000 description 5
- 241001515965 unidentified phage Species 0.000 description 5
- 239000011720 vitamin B Substances 0.000 description 5
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 4
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- 241000193469 Clostridium pasteurianum Species 0.000 description 4
- 108091026890 Coding region Proteins 0.000 description 4
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 4
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 238000002105 Southern blotting Methods 0.000 description 4
- 239000007983 Tris buffer Substances 0.000 description 4
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 4
- 238000000137 annealing Methods 0.000 description 4
- 230000004071 biological effect Effects 0.000 description 4
- 230000006037 cell lysis Effects 0.000 description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 4
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 4
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000013613 expression plasmid Substances 0.000 description 4
- 125000001165 hydrophobic group Chemical group 0.000 description 4
- 238000003780 insertion Methods 0.000 description 4
- 230000037431 insertion Effects 0.000 description 4
- 238000012423 maintenance Methods 0.000 description 4
- 230000003647 oxidation Effects 0.000 description 4
- 238000007254 oxidation reaction Methods 0.000 description 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 230000003362 replicative effect Effects 0.000 description 4
- 238000012216 screening Methods 0.000 description 4
- UNFWWIHTNXNPBV-WXKVUWSESA-N spectinomycin Chemical compound O([C@@H]1[C@@H](NC)[C@@H](O)[C@H]([C@@H]([C@H]1O1)O)NC)[C@]2(O)[C@H]1O[C@H](C)CC2=O UNFWWIHTNXNPBV-WXKVUWSESA-N 0.000 description 4
- 229960000268 spectinomycin Drugs 0.000 description 4
- 238000010561 standard procedure Methods 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 238000013519 translation Methods 0.000 description 4
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 4
- 230000035899 viability Effects 0.000 description 4
- 239000011715 vitamin B12 Substances 0.000 description 4
- OAJLVMGLJZXSGX-SLAFOUTOSA-L (2s,3s,4r,5r)-2-(6-aminopurin-9-yl)-5-methanidyloxolane-3,4-diol;cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7 Chemical compound [Co+3].O[C@H]1[C@@H](O)[C@@H]([CH2-])O[C@@H]1N1C2=NC=NC(N)=C2N=C1.[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O OAJLVMGLJZXSGX-SLAFOUTOSA-L 0.000 description 3
- AZKSAVLVSZKNRD-UHFFFAOYSA-M 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide Chemical compound [Br-].S1C(C)=C(C)N=C1[N+]1=NC(C=2C=CC=CC=2)=NN1C1=CC=CC=C1 AZKSAVLVSZKNRD-UHFFFAOYSA-M 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- 101100228930 Citrobacter freundii dhaD gene Proteins 0.000 description 3
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 3
- 108700010070 Codon Usage Proteins 0.000 description 3
- 241000195493 Cryptophyta Species 0.000 description 3
- 102000053602 DNA Human genes 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 description 3
- 101150004714 GPP1 gene Proteins 0.000 description 3
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 3
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 3
- 101000907829 Klebsiella pneumoniae 1,3-propanediol dehydrogenase Proteins 0.000 description 3
- 241001055489 Klebsiella pneumoniae ATCC 25955 Species 0.000 description 3
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 3
- 240000001929 Lactobacillus brevis Species 0.000 description 3
- 235000013957 Lactobacillus brevis Nutrition 0.000 description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 3
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 3
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 3
- 108091034117 Oligonucleotide Proteins 0.000 description 3
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 3
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 3
- 108091081024 Start codon Proteins 0.000 description 3
- 101150033985 TPI gene Proteins 0.000 description 3
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 3
- 108010084455 Zeocin Proteins 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 235000004279 alanine Nutrition 0.000 description 3
- 150000001299 aldehydes Chemical class 0.000 description 3
- 230000031018 biological processes and functions Effects 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 238000004422 calculation algorithm Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 description 3
- 238000006555 catalytic reaction Methods 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000005515 coenzyme Substances 0.000 description 3
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 3
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 3
- 230000007062 hydrolysis Effects 0.000 description 3
- 238000006460 hydrolysis reaction Methods 0.000 description 3
- 238000011081 inoculation Methods 0.000 description 3
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 3
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 3
- 239000011565 manganese chloride Substances 0.000 description 3
- 238000001819 mass spectrum Methods 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 230000001404 mediated effect Effects 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- CWCMIVBLVUHDHK-ZSNHEYEWSA-N phleomycin D1 Chemical compound N([C@H](C(=O)N[C@H](C)[C@@H](O)[C@H](C)C(=O)N[C@@H]([C@H](O)C)C(=O)NCCC=1SC[C@@H](N=1)C=1SC=C(N=1)C(=O)NCCCCNC(N)=N)[C@@H](O[C@H]1[C@H]([C@@H](O)[C@H](O)[C@H](CO)O1)O[C@@H]1[C@H]([C@@H](OC(N)=O)[C@H](O)[C@@H](CO)O1)O)C=1N=CNC=1)C(=O)C1=NC([C@H](CC(N)=O)NC[C@H](N)C(N)=O)=NC(N)=C1C CWCMIVBLVUHDHK-ZSNHEYEWSA-N 0.000 description 3
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 3
- 239000008057 potassium phosphate buffer Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 238000012163 sequencing technique Methods 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 229960000344 thiamine hydrochloride Drugs 0.000 description 3
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 3
- 239000011747 thiamine hydrochloride Substances 0.000 description 3
- 238000013518 transcription Methods 0.000 description 3
- 230000035897 transcription Effects 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 2
- 101100409109 Caenorhabditis elegans pqn-8 gene Proteins 0.000 description 2
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 2
- 241000193171 Clostridium butyricum Species 0.000 description 2
- 108010051219 Cre recombinase Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-M D-gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O RGHNJXZEOKUKBD-SQOUGZDYSA-M 0.000 description 2
- ZAQJHHRNXZUBTE-UHFFFAOYSA-N D-threo-2-Pentulose Natural products OCC(O)C(O)C(=O)CO ZAQJHHRNXZUBTE-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 238000007399 DNA isolation Methods 0.000 description 2
- 238000001712 DNA sequencing Methods 0.000 description 2
- 241000588722 Escherichia Species 0.000 description 2
- 230000005526 G1 to G0 transition Effects 0.000 description 2
- 108010015895 Glycerone kinase Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 101001072574 Homo sapiens Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic Proteins 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 102000008133 Iron-Binding Proteins Human genes 0.000 description 2
- 108010035210 Iron-Binding Proteins Proteins 0.000 description 2
- 241000588915 Klebsiella aerogenes Species 0.000 description 2
- 241000588749 Klebsiella oxytoca Species 0.000 description 2
- 201000008225 Klebsiella pneumonia Diseases 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- 241000186679 Lactobacillus buchneri Species 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 239000007993 MOPS buffer Substances 0.000 description 2
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 2
- 206010035717 Pneumonia klebsiella Diseases 0.000 description 2
- NBBJYMSMWIIQGU-UHFFFAOYSA-N Propionic aldehyde Chemical compound CCC=O NBBJYMSMWIIQGU-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 241000588717 Shimwellia blattae Species 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108010006785 Taq Polymerase Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 108700040099 Xylose isomerases Proteins 0.000 description 2
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 229960005305 adenosine Drugs 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 125000001931 aliphatic group Chemical group 0.000 description 2
- 125000000539 amino acid group Chemical group 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- OWMVSZAMULFTJU-UHFFFAOYSA-N bis-tris Chemical compound OCCN(CCO)C(CO)(CO)CO OWMVSZAMULFTJU-UHFFFAOYSA-N 0.000 description 2
- 210000004899 c-terminal region Anatomy 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000001569 carbon dioxide Substances 0.000 description 2
- 229910002091 carbon monoxide Inorganic materials 0.000 description 2
- 230000010261 cell growth Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 230000005465 channeling Effects 0.000 description 2
- 239000013043 chemical agent Substances 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- JBJSVEVEEGOEBZ-SCZZXKLOSA-K coenzyme B(3-) Chemical compound [O-]P(=O)([O-])O[C@H](C)[C@@H](C([O-])=O)NC(=O)CCCCCCS JBJSVEVEEGOEBZ-SCZZXKLOSA-K 0.000 description 2
- 239000002299 complementary DNA Substances 0.000 description 2
- 238000004590 computer program Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 229940104302 cytosine Drugs 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 230000009483 enzymatic pathway Effects 0.000 description 2
- 239000013604 expression vector Substances 0.000 description 2
- 238000007429 general method Methods 0.000 description 2
- 101150071897 glpF gene Proteins 0.000 description 2
- 229940050410 gluconate Drugs 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- LXJXRIRHZLFYRP-UHFFFAOYSA-N glyceraldehyde 3-phosphate Chemical compound O=CC(O)COP(O)(O)=O LXJXRIRHZLFYRP-UHFFFAOYSA-N 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 230000006801 homologous recombination Effects 0.000 description 2
- 238000002744 homologous recombination Methods 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 238000001155 isoelectric focusing Methods 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 2
- 238000002703 mutagenesis Methods 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 229950006238 nadide Drugs 0.000 description 2
- 238000007857 nested PCR Methods 0.000 description 2
- 238000010899 nucleation Methods 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 230000026731 phosphorylation Effects 0.000 description 2
- 238000006366 phosphorylation reaction Methods 0.000 description 2
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 2
- 238000007747 plating Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229910000027 potassium carbonate Inorganic materials 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 2
- 230000008929 regeneration Effects 0.000 description 2
- 238000011069 regeneration method Methods 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000011684 sodium molybdate Substances 0.000 description 2
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-L sulfite Chemical class [O-]S([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-L 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000001890 transfection Methods 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 108700026220 vif Genes Proteins 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- CYNAPIVXKRLDER-LBPRGKRZSA-N (2s)-2-benzamido-3-(4-hydroxy-3-nitrophenyl)propanoic acid Chemical compound C([C@@H](C(=O)O)NC(=O)C=1C=CC=CC=1)C1=CC=C(O)C([N+]([O-])=O)=C1 CYNAPIVXKRLDER-LBPRGKRZSA-N 0.000 description 1
- FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 101150028074 2 gene Proteins 0.000 description 1
- RZYHXKLKJRGJGP-UHFFFAOYSA-N 2,2,2-trifluoro-n,n-bis(trimethylsilyl)acetamide Chemical compound C[Si](C)(C)N([Si](C)(C)C)C(=O)C(F)(F)F RZYHXKLKJRGJGP-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QGZCUOLOTMJILH-UHFFFAOYSA-N 2h-tetrazol-2-ium;bromide Chemical compound [Br-].C1=N[NH+]=NN1 QGZCUOLOTMJILH-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 1
- QYNUQALWYRSVHF-ABLWVSNPSA-N 5,10-methylenetetrahydrofolic acid Chemical compound C1N2C=3C(=O)NC(N)=NC=3NCC2CN1C1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 QYNUQALWYRSVHF-ABLWVSNPSA-N 0.000 description 1
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 description 1
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 1
- PJWIPEXIFFQAQZ-PUFIMZNGSA-N 7-phospho-2-dehydro-3-deoxy-D-arabino-heptonic acid Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@H](O)CC(=O)C(O)=O PJWIPEXIFFQAQZ-PUFIMZNGSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229920000936 Agarose Polymers 0.000 description 1
- 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
- 102100036826 Aldehyde oxidase Human genes 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000153158 Ammi visnaga Species 0.000 description 1
- 235000010585 Ammi visnaga Nutrition 0.000 description 1
- 241000196312 Asteromonas gracilis Species 0.000 description 1
- 241000194108 Bacillus licheniformis Species 0.000 description 1
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 238000009010 Bradford assay Methods 0.000 description 1
- 241000178343 Butea superba Species 0.000 description 1
- 101000907830 Citrobacter freundii 1,3-propanediol dehydrogenase Proteins 0.000 description 1
- 101100135918 Citrobacter freundii pduG gene Proteins 0.000 description 1
- 241001112696 Clostridia Species 0.000 description 1
- 206010010144 Completed suicide Diseases 0.000 description 1
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 1
- XPYBSIWDXQFNMH-UHFFFAOYSA-N D-fructose 1,6-bisphosphate Natural products OP(=O)(O)OCC(O)C(O)C(O)C(=O)COP(O)(O)=O XPYBSIWDXQFNMH-UHFFFAOYSA-N 0.000 description 1
- MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 1
- 230000003682 DNA packaging effect Effects 0.000 description 1
- 230000008265 DNA repair mechanism Effects 0.000 description 1
- 101710126179 Dihydroxyacetone kinase Proteins 0.000 description 1
- 206010059866 Drug resistance Diseases 0.000 description 1
- 241001560459 Dunaliella sp. Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000701832 Enterobacteria phage T3 Species 0.000 description 1
- 101100213623 Escherichia coli (strain K12) yiiQ gene Proteins 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- 102100026859 FAD-AMP lyase (cyclizing) Human genes 0.000 description 1
- 101710130885 FAD-AMP lyase (cyclizing) Proteins 0.000 description 1
- 108020000296 FAD-dependent glycerol-3-phosphate dehydrogenase Proteins 0.000 description 1
- 102000002779 FAD-dependent glycerol-3-phosphate dehydrogenase Human genes 0.000 description 1
- 229910005390 FeSO4-7H2O Inorganic materials 0.000 description 1
- 229910005444 FeSO4—7H2O Inorganic materials 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108010001498 Galectin 1 Proteins 0.000 description 1
- 102100021736 Galectin-1 Human genes 0.000 description 1
- 102100024637 Galectin-10 Human genes 0.000 description 1
- 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
- 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 101710184498 Glycerol uptake facilitator protein Proteins 0.000 description 1
- 108030001219 Glycerol-3-phosphate dehydrogenases Proteins 0.000 description 1
- 101710171812 Glycerol-3-phosphate phosphatase Proteins 0.000 description 1
- 101150009006 HIS3 gene Proteins 0.000 description 1
- 101100246753 Halobacterium salinarum (strain ATCC 700922 / JCM 11081 / NRC-1) pyrF gene Proteins 0.000 description 1
- 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
- 101000928314 Homo sapiens Aldehyde oxidase Proteins 0.000 description 1
- 101000655188 Homo sapiens Tachykinin-3 Proteins 0.000 description 1
- 101001046426 Homo sapiens cGMP-dependent protein kinase 1 Proteins 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 241000411968 Ilyobacter Species 0.000 description 1
- 241000411974 Ilyobacter polytropus Species 0.000 description 1
- 108020005350 Initiator Codon Proteins 0.000 description 1
- 108091029795 Intergenic region Proteins 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 239000007836 KH2PO4 Substances 0.000 description 1
- 101100498822 Klebsiella oxytoca (strain ATCC 8724 / DSM 4798 / JCM 20051 / NBRC 3318 / NRRL B-199 / KCTC 1686) ddrA gene Proteins 0.000 description 1
- 101100498826 Klebsiella oxytoca (strain ATCC 8724 / DSM 4798 / JCM 20051 / NBRC 3318 / NRRL B-199 / KCTC 1686) ddrB gene Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000007987 MES buffer Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229910017621 MgSO4-7H2O Inorganic materials 0.000 description 1
- 229910017234 MnSO4 H2O Inorganic materials 0.000 description 1
- 229910017237 MnSO4-H2O Inorganic materials 0.000 description 1
- 229910017228 MnSO4—H2O Inorganic materials 0.000 description 1
- 108010086093 Mung Bean Nuclease Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 229910017912 NH2OH Inorganic materials 0.000 description 1
- 229930193140 Neomycin Natural products 0.000 description 1
- 101100062121 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) cyc-1 gene Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 108020005187 Oligonucleotide Probes Proteins 0.000 description 1
- 101150012394 PHO5 gene Proteins 0.000 description 1
- 101150038013 PIR gene Proteins 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 241000863392 Pelobacter Species 0.000 description 1
- 101710188351 Phosphoenolpyruvate-dependent phosphotransferase system Proteins 0.000 description 1
- 108700019535 Phosphoprotein Phosphatases Proteins 0.000 description 1
- 101710165249 Probable NADH-dependent butanol dehydrogenase 2 Proteins 0.000 description 1
- 102000007327 Protamines Human genes 0.000 description 1
- 108010007568 Protamines Proteins 0.000 description 1
- 101100505872 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) xcpT gene Proteins 0.000 description 1
- 101100016013 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) xcpU gene Proteins 0.000 description 1
- 101100016023 Pseudomonas aeruginosa (strain ATCC 15692 / DSM 22644 / CIP 104116 / JCM 14847 / LMG 12228 / 1C / PRS 101 / PAO1) xcpV gene Proteins 0.000 description 1
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 1
- 108020004511 Recombinant DNA Proteins 0.000 description 1
- 108700005075 Regulator Genes Proteins 0.000 description 1
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 1
- 101100434411 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) ADH1 gene Proteins 0.000 description 1
- 244000206963 Saccharomyces cerevisiae var. diastaticus Species 0.000 description 1
- 101100135913 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) pduC gene Proteins 0.000 description 1
- 101100135914 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) pduD gene Proteins 0.000 description 1
- 101100135915 Salmonella typhimurium (strain LT2 / SGSC1412 / ATCC 700720) pduE gene Proteins 0.000 description 1
- 101001000154 Schistosoma mansoni Phosphoglycerate kinase Proteins 0.000 description 1
- 108020004682 Single-Stranded DNA Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021536 Sugar beet Nutrition 0.000 description 1
- 239000012505 Superdex™ Substances 0.000 description 1
- 108700005078 Synthetic Genes Proteins 0.000 description 1
- 102100033009 Tachykinin-3 Human genes 0.000 description 1
- 101710195626 Transcriptional activator protein Proteins 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 102100033598 Triosephosphate isomerase Human genes 0.000 description 1
- 101150050575 URA3 gene Proteins 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000000370 acceptor Substances 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000999 acridine dye Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 101150102866 adc1 gene Proteins 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 101150066782 adhB gene Proteins 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000037358 bacterial metabolism Effects 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 238000010256 biochemical assay Methods 0.000 description 1
- 238000010170 biological method Methods 0.000 description 1
- 239000001045 blue dye Substances 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- ZTQSAGDEMFDKMZ-UHFFFAOYSA-N butyric aldehyde Natural products CCCC=O ZTQSAGDEMFDKMZ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 102100022422 cGMP-dependent protein kinase 1 Human genes 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 150000001721 carbon Chemical class 0.000 description 1
- 150000001722 carbon compounds Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000006727 cell loss Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 238000001311 chemical methods and process Methods 0.000 description 1
- 239000002962 chemical mutagen Substances 0.000 description 1
- 210000003763 chloroplast Anatomy 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- XLJKHNWPARRRJB-UHFFFAOYSA-N cobalt(2+) Chemical class [Co+2] XLJKHNWPARRRJB-UHFFFAOYSA-N 0.000 description 1
- ZIHHMGTYZOSFRC-UWWAPWIJSA-M cobamamide Chemical compound C1(/[C@](C)(CCC(=O)NC[C@H](C)OP(O)(=O)OC2[C@H]([C@H](O[C@@H]2CO)N2C3=CC(C)=C(C)C=C3N=C2)O)[C@@H](CC(N)=O)[C@]2(N1[Co+]C[C@@H]1[C@H]([C@@H](O)[C@@H](O1)N1C3=NC=NC(N)=C3N=C1)O)[H])=C(C)\C([C@H](C/1(C)C)CCC(N)=O)=N\C\1=C/C([C@H]([C@@]\1(CC(N)=O)C)CCC(N)=O)=N/C/1=C(C)\C1=N[C@]2(C)[C@@](C)(CC(N)=O)[C@@H]1CCC(N)=O ZIHHMGTYZOSFRC-UWWAPWIJSA-M 0.000 description 1
- 239000011789 cobamamide Substances 0.000 description 1
- 235000006279 cobamamide Nutrition 0.000 description 1
- XQRJFEVDQXEIAX-JFYQDRLCSA-M cobinamide Chemical compound [Co]N([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@H](O)C)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O XQRJFEVDQXEIAX-JFYQDRLCSA-M 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000003636 conditioned culture medium Substances 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- WUPRCGRRQUZFAB-DEGKJRJSSA-N corrin Chemical group N1C2CC\C1=C\C(CC/1)=N\C\1=C/C(CC\1)=N/C/1=C\C1=NC2CC1 WUPRCGRRQUZFAB-DEGKJRJSSA-N 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000002577 cryoprotective agent Substances 0.000 description 1
- 150000001923 cyclic compounds Chemical class 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 101150011756 ddrA gene Proteins 0.000 description 1
- 101150073964 ddrB gene Proteins 0.000 description 1
- 238000001212 derivatisation Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000007323 disproportionation reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000386 donor Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000007824 enzymatic assay Methods 0.000 description 1
- 230000009088 enzymatic function Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- FVTCRASFADXXNN-SCRDCRAPSA-N flavin mononucleotide Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O FVTCRASFADXXNN-SCRDCRAPSA-N 0.000 description 1
- 150000002211 flavins Chemical class 0.000 description 1
- 238000011010 flushing procedure Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000004459 forage Substances 0.000 description 1
- 231100000221 frame shift mutation induction Toxicity 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- RNBGYGVWRKECFJ-UHFFFAOYSA-N fructose-1,6-phosphate Natural products OC1C(O)C(O)(COP(O)(O)=O)OC1COP(O)(O)=O RNBGYGVWRKECFJ-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000007863 gel particle Substances 0.000 description 1
- 238000003209 gene knockout Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 101150024374 glpX gene Proteins 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N glycerol 1-phosphate Chemical compound OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 108010000361 glycerol 2-dehydrogenase (NADP+) Proteins 0.000 description 1
- PEDCQBHIVMGVHV-VMIGTVKRSA-N glycerol-13c3 Chemical compound O[13CH2][13CH](O)[13CH2]O PEDCQBHIVMGVHV-VMIGTVKRSA-N 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 239000000852 hydrogen donor Substances 0.000 description 1
- 238000007901 in situ hybridization Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000003999 initiator Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 125000000468 ketone group Chemical group 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000012160 loading buffer Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ISPYRSDWRDQNSW-UHFFFAOYSA-L manganese(II) sulfate monohydrate Chemical compound O.[Mn+2].[O-]S([O-])(=O)=O ISPYRSDWRDQNSW-UHFFFAOYSA-L 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108020004999 messenger RNA Proteins 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000006151 minimal media Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 238000001823 molecular biology technique Methods 0.000 description 1
- MEFBJEMVZONFCJ-UHFFFAOYSA-N molybdate Chemical compound [O-][Mo]([O-])(=O)=O MEFBJEMVZONFCJ-UHFFFAOYSA-N 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 230000012666 negative regulation of transcription by glucose Effects 0.000 description 1
- 229960004927 neomycin Drugs 0.000 description 1
- HYIMSNHJOBLJNT-UHFFFAOYSA-N nifedipine Chemical compound COC(=O)C1=C(C)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1[N+]([O-])=O HYIMSNHJOBLJNT-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 238000007899 nucleic acid hybridization Methods 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 239000002751 oligonucleotide probe Substances 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 230000008723 osmotic stress Effects 0.000 description 1
- 238000012858 packaging process Methods 0.000 description 1
- FIKAKWIAUPDISJ-UHFFFAOYSA-L paraquat dichloride Chemical compound [Cl-].[Cl-].C1=C[N+](C)=CC=C1C1=CC=[N+](C)C=C1 FIKAKWIAUPDISJ-UHFFFAOYSA-L 0.000 description 1
- 101150097419 pduH gene Proteins 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229930029653 phosphoenolpyruvate Natural products 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- GNSKLFRGEWLPPA-UHFFFAOYSA-M potassium dihydrogen phosphate Chemical compound [K+].OP(O)([O-])=O GNSKLFRGEWLPPA-UHFFFAOYSA-M 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000013630 prepared media Substances 0.000 description 1
- 230000019525 primary metabolic process Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical class CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- CMDGQTVYVAKDNA-UHFFFAOYSA-N propane-1,2,3-triol;hydrate Chemical compound O.OCC(O)CO CMDGQTVYVAKDNA-UHFFFAOYSA-N 0.000 description 1
- 229950008679 protamine sulfate Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 239000011802 pulverized particle Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 230000027756 respiratory electron transport chain Effects 0.000 description 1
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000006152 selective media Substances 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 101150019193 sldA gene Proteins 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 125000003831 tetrazolyl group Chemical group 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000036962 time dependent Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- AUALKMYBYGCYNY-UHFFFAOYSA-E triazanium;2-hydroxypropane-1,2,3-tricarboxylate;iron(3+) Chemical compound [NH4+].[NH4+].[NH4+].[Fe+3].[Fe+3].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O AUALKMYBYGCYNY-UHFFFAOYSA-E 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 101150020055 yiiR gene Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/18—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic polyhydric
Definitions
- This invention comprises process for the bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism.
- 1,3-Propanediol is a monomer having potential utility in the production of polyester fibers and the manufacture of polyurethanes and cyclic compounds.
- a variety of chemical routes to 1,3-propanediol are known.
- ethylene oxide may be converted to 1,3-propanediol over a catalyst in the presence of phosphine, water, carbon monoxide, hydrogen and an acid, by the catalytic solution phase hydration of acrolein followed by reduction, or from compounds such as glycerol, reacted in the presence of carbon monoxide and hydrogen over catalysts having atoms from group VIII of the periodic table.
- 1,3-propanediol can be produced from the fermentation of glycerol.
- Bacterial strains able to produce 1 ,3-propanediol have been found, for example, in the groups Citrobacter,
- glycerol is converted to 1,3-propanediol in a two step, enzyme catalyzed reaction sequence.
- a dehydratase catalyzes the conversion of glycerol to 3-hydroxypropionaldehyde (3-HPA) and water, Equation 1.
- 3-HPA is reduced to 1,3-propanediol by a NAD + -linked oxidoreductase, Equation 2.
- the 1,3-propanediol is not metabolized further and, as a result,
- NADH reduced ⁇ -nicotinamide adenine dinucleotide
- NAD + nicotinamide adenine dinucleotide
- Klebsiella pneumonia, Citrobacter freundii, and Clostridium pasteurianum the genes encoding the three structural subunits of glycerol dehydratase (dhaBI -3 or dhaB, C and E) are located adjacent to a gene encoding a specific 1,3-propanediol oxidoreductase (dhaT) (see Figure 1).
- genes are clustered in a group which also comprises orfX and orfZ (genes encoding a dehydratase reactivation factor for glycerol dehydratase), as well as orfY and orfW (genes of unknown function).
- the specific 1,3-propanediol oxidoreductases (dh ⁇ Ts) of these microorganisms are known to belong to the family of type III alcohol dehydrogenases; each exhibits a conserved iron-binding motif and has a preference for the NAD + /NADH linked interconversion of 1,3-propandiol and 3-HPA.
- NAD + /NADH linked interconversion of 1,3-propandiol and 3-HPA is also catalyzed by alcohol dehydrogenases which are not specifically linked to dehydratase enzymes (for example, horse liver and baker's yeast alcohol dehydrogenases (E.C. 1.1.1.1)), albeit with less efficient kinetic parameters.
- alcohol dehydrogenases which are not specifically linked to dehydratase enzymes (for example, horse liver and baker's yeast alcohol dehydrogenases (E.C. 1.1.1.1)), albeit with less efficient kinetic parameters.
- Glycerol dehydratase (E.C. 4.2.1.30) and diol [1,2-propanediol] dehydratase (E.C. 4.2.1.28) are related but distinct enzymes that are encoded by distinct genes.
- Diol dehydratase genes from Klebsiella oxytoca and Salmonella typhimurium are similar to glycerol dehydratase genes and are clustered in a group which comprises genes analogous to orfX and orfZ (Daniel et al., FEMS Microbiol Rev. 22, 553 (1999); Toraya and Mori, J. Biol. Chem. 274, 3372 (1999); GenBank AF026270).
- 1,3-propanediol from glycerol is generally performed under anaerobic conditions using glycerol as the sole carbon source and in the absence of other exogenous reducing equivalent acceptors.
- glycerol as the sole carbon source and in the absence of other exogenous reducing equivalent acceptors.
- a parallel pathway for glycerol operates which first involves oxidation of glycerol to dihydroxyacetone (DHA) by a NAD + - (or NADP + -) linked glycerol dehydrogenase, Equation 3.
- DHA dihydroxyacetone
- DHAP dihydroxyacetone phosphate
- DHA kinase Equation 4
- this pathway may provide carbon and energy to the cell and produces rather than consumes NADH.
- dhaB glycerol dehydratase
- dhaT 1,3-propanediol oxidoreductase
- dhaD glycerol dehydrogenase
- dhaK dihydroxyacetone kinase
- the dha regulon in Klebsiella pneumoniae and Citrobacter freundii, also encompasses a gene encoding a transcriptional activator protein (dhaR).
- dha regulons from Citrobacter and Klebsiella have been expressed in Escherichia coli and have been shown to convert glycerol to 1,3-propanediol.
- glycerol Biological processes for the preparation of glycerol are known.
- the overwhelming majority of glycerol producers are yeasts but some bacteria, other fungi and algae are also known. Both bacteria and yeasts produce glycerol by converting glucose or other carbohydrates through the fructose- 1,6-bisphosphate pathway in glycolysis or the Embden Meyerhof Parnas pathway, whereas, certain algae convert dissolved carbon dioxide or bicarbonate in the chloroplasts into the 3-carbon intermediates of the Calvin cycle.
- the 3-carbon intermediate, phosphogly eerie acid is converted to glyceraldehyde 3 -phosphate which can be readily interconverted to its keto isomer dihydroxyacetone phosphate and ultimately to glycerol.
- Bacillus licheniformis and Lactobacillus lycopersica synthesize glycerol, and glycerol production is found in the halotolerant algae Dunaliella sp. and Asteromonas gracilis for protection against high external salt concentrations.
- various osmotolerant yeasts synthesize glycerol as a protective measure.
- Most strains of Saccharomyces produce some glycerol during alcoholic fermentation, and this can be increased physiologically by the application of osmotic stress.
- commercial glycerol production was achieved by the use of Saccharomyces cultures to which "steering reagents" were added such as sulfites or alkalis.
- the steering agents block or inhibit the conversion of acetaldehyde to ethanol; thus, excess reducing equivalents (NADH) are available to or "steered” towards DHAP for reduction to produce glycerol.
- NADH reducing equivalents
- This method is limited by the partial inhibition of yeast growth that is due to the sulfites.
- This limitation can be partially overcome by the use of alkalis that create excess NADH equivalents by a different mechanism. In this practice, the alkalis initiated a Cannizarro disproportionation to yield ethanol and acetic acid from two equivalents of acetaldehyde.
- the gene encoding glycerol-3 -phosphate dehydrogenase has been cloned and sequenced from S. diastaticus (Wang et al., J. Bact. 176, 7091-7095 (1994)).
- the DARl gene was cloned into a shuttle vector and used to transform E coli where expression produced active enzyme. Wang et al. (supra) recognize that DARl is regulated by the cellular osmotic environment but do not suggest how the gene might be used to enhance 1,3-propanediol production in a recombinant microorganism.
- glycerol-3 -phosphate dehydrogenase enzymes have been isolated: for example, sn-glycerol-3 -phosphate dehydrogenase has been cloned and sequenced from Saccharomyces cerevisiae (Larason et al., Mol. Microbiol. 10, 1101 (1993)) and Albertyn et al. (Mol. Cell. Biol. 14, 4135 (1994)) teach the cloning of GPD1 encoding a glycerol-3 -phosphate dehydrogenase from Saccharomyces cerevisiae. Like Wang et al. (supra), both Albertyn et al. and Larason et al. recognize the osmo-sensitivity of the regulation of this gene but do not suggest how the gene might be used in the production of 1,3-propanediol in a recombinant microorganism.
- glycerol-3-phosphatase has been isolated from Saccharomyces cerevisiae and the protein identified as being encoded by the
- GPP1 and GPP2 genes (Norbeck et al., J Biol. Chem. 271, 13875 (1996)). Like the genes encoding G3PDH, it appears that GPP2 is osmosensitive.
- Gottschalk et al. ( ⁇ P 373 230) teach that the growth of most strains useful for the production of 1,3-propanediol, including Citrobacter freundii, Clostridium autobutylicum, Clostridium butylicum, and Klebsiella pneumoniae, is disturbed by the presence of a hydrogen donor such as fructose or glucose.
- Lactobacillus brevis and Lactobacillus buchner which produce 1,3-propanediol in co-fermentations of glycerol and fructose or glucose, do not grow when glycerol is provided as the sole carbon source, and, although it has been shown that resting cells can metabolize glucose or fructose, they do not produce 1,3-propanediol (Veiga DA Cunha et al., J. Bacteriol, 174, 1013 (1992)).
- 1,3-propanediol is produced in the absence of glycerol (Tong et al., supra.).
- single microorganisms use the carbohydrate as a source of generating NADH while providing energy and carbon for cell maintenance or growth.
- the problem that remains to be solved is how to biologically produce 1,3-propanediol, with high titer and by a single microorganism, from an inexpensive carbon substrate such as glucose or other sugars.
- the biological production of 1,3-propanediol requires glycerol as a substrate for a two-step sequential reaction in which a dehydratase enzyme (typically a coenzyme Bj2-dependent dehydratase) converts glycerol to an intermediate, 3-hydroxypropionaldehyde, which is then reduced to 1,3-propanediol by a dehydratase enzyme (typically a coenzyme Bj2-dependent dehydratase) converts glycerol to an intermediate, 3-hydroxypropionaldehyde, which is then reduced to 1,3-propanediol by a
- a dehydratase enzyme typically a coenzyme Bj2-dependent dehydratase
- NADH- (or NADPH) dependent oxidoreductase The complexity of the cofactor requirements necessitates the use of a whole cell catalyst for an industrial process that utilizes this reaction sequence for the production of 1,3-propanediol.
- Applicants have solved the stated problem and the present invention provides for bioconverting a fermentable carbon source directly to 1,3-propanediol at significantly higher titer than previously obtained and with the use of a single microorganism.
- Glucose is used as a model substrate and E. coli is used as the model host.
- coli expressing a group of genes comprising genes that encode a dehydratase activity, a dehydratase reactivation factor, a 1,3-propanediol oxidoreductase (dhaT), a glycerol-3-phosphate dehydrogenase, and a glycerol-3 -phosphatase) convert glucose to 1,3-propanediol at titer that approaches that of glycerol to 1 ,3-propanediol fermentations.
- dhaT 1,3-propanediol oxidoreductase
- glycerol-3-phosphate dehydrogenase 1,3-propanediol oxidoreductase
- glycerol-3 -phosphatase 1,3-propanediol oxidoreductase
- coli results in a significantly higher titer of 1,3-propanediol from glucose.
- This unexpected increase in titer results in improved economics, and thus, an improved process for the production of 1,3-propanediol from glucose.
- the present invention may be generally applied to include any carbon substrate that is readily converted to 1) glycerol, 2) dihydroxyacetone,
- This activity has been isolated from E. coli as a nucleic acid fragment encoding a non-specific catalytic activity for the conversion of 3- hydroxypropionaldehyde to 1,3-propanediol, as set out in S ⁇ Q ID NO:58 or as selected from the group consisting of:
- chimeric gene may be constructed comprising the isolated nucleic acid fragment described above operably linked to suitable regulatory sequences.
- This chimeric gene can be used to transform crroorganisms selected from the group consisting of Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Salmonella, Bacillus, Aerobacter, Streptomyces, Escherichia, and Pseudomonas.
- E. coli is the preferred host.
- the present invention provides a recombinant microorganism, useful for the production of 1,3-propanediol comprising: (a) at least one gene encoding a polypeptide having glycerol-3 -phosphate dehydrogenase activity; (b) at least one gene encoding a polypeptide having glycerol-3-phosphatase activity; (c) at least one gene encoding a polypeptide having a dehydratase activity; (d) at least one gene encoding a dehydratase reactivation factor; (e) at least one endogenous gene encoding an non-specific catalytic activity sufficient to convert 3 -hydroxypropionaldehyde to 1,3-propanediol, wherein no functional dhaT gene encoding a 1,3-propanediol oxidoreductase is present.
- the preferred embodiment is a recombinant microorganism (preferably E. coli) where no dhaT gene is present.
- the recombinant microorganism may comprise mutations (e.g., deletion mutations or point mutations) in endogenous genes selected from the group consisting of: (a) a gene encoding a polypeptide having glycerol kinase activity; (b) a gene encoding a polypeptide having glycerol dehydrogenase activity; and (c) gene encoding a polypeptide having triosephosphate isomerase activity.
- the invention includes a process for the production of 1,3-propanediol comprising: (a) contacting, under suitable conditions, a recombinant E. coli comprising a dha regulon and lacking a functional dhaT gene encoding a 1,3-propanediol oxidoreductase activity with at least one carbon source, wherein the carbon source is selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates; and (b) optionally recovering the 1,3-propanediol produced in (a).
- the invention also provides a process for the production of 1,3-propanediol from a recombinant microorganism comprising: (a) contacting the recombinant microorganism of the present invention with at least one carbon source selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates whereby 1 ,3-propanediol is produced; and (b) optionally recovering the 1,3-propanediol produced in (a).
- the invention intends to provide a process for the production of 1,3-propanediol from a recombinant microorganism comprising: (a) contacting a recombinant microorganism with at least one carbon source, said recombinant microorganism comprising:
- coli comprising: (i) at least one exogenous gene encoding a polypeptide having a dehydratase activity; (ii) at least one exogenous gene encoding a dehydratase reactivation factor; (iii) at least one exogenous gene encoding a non-specific catalytic activity sufficient to convert 3 -hydroxypropionaldehyde to 1,3-propanediol, wherein no functional dhaT gene encoding a 1,3-propanediol oxidoreductase activity is present in the recombinant E.
- said first carbon source is selected from the group consisting of glycerol and dihydroxyacetone
- said second carbon source is selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates
- the 1,3-propanediol produced in (a) is optionally recovered.
- the co-feed may be sequential or simultaneous.
- the recombinant E is selected from the group consisting of glycerol and dihydroxyacetone
- said second carbon source is selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates
- coli used in a co-feeding embodiemtn may further comprise: (a) a set of exogenous genes consisting of (i) at least one gene encoding a polypeptide having glycerol-3 -phosphate dehydrogenase activity; (ii) at least one gene encoding a polypeptide having glycerol-3-phosphatase activity; and (iii) at least one subset of genes encoding the gene products oidhaR, orfY, orfX, orfW, dhaBI, dhaB2, dhaB3 and orfZ, and (b) a set of endogenous genes, each gene having a mutation inactivating the gene, the set consisting of: (i) a gene encoding a polypeptide having glycerol kinase activity; (ii) a gene encoding a polypeptide having glycerol dehydrogenase activity; and (iii) a gene encoding
- KLP23 comprising: (a) a set of two endogenous genes, each gene having a mutation inactivating the gene, the set consisting of: (i) a gene encoding a polypeptide having a glycerol kinase activity; and (ii) a gene encoding a polypeptide having a glycerol dehydrogenase activity; (b) at least one exogenous gene encoding a polypeptide having glycerol-3-phosphate dehydrogenase activity; (c) at least one exogenous gene encoding a polypeptide having glycerol-3- phosphatase activity; and (d) a plasmid pKP32 and a recombinant E coli strain RJ8 comprising: (a) set of three endogenous genes, each gene having a mutation inactivating the gene, the set consisting of: (i) a gene encoding a polypeptide having a glycerol kina
- E. coli comprising: (a) a set of exogenous genes consisting of: (i) at least one gene encoding a polypeptide having a dehydratase activity; (ii) at least one gene encoding a polypeptide having glycerol-3 -phosphate dehydrogenase activity; (iii) at least one gene encoding a polypeptide having glycerol-3-phosphatase activity; and (iv) at least one gene encoding a dehydratase reactivation factor; and (b) at least one endogenous gene encoding a non-specific catalytic activity to convert 3 -hydroxypropionaldehyde to 1,3-propanediol; wherein no functional dhaT gene encoding a 1,3-propanediol oxidoreductase activity is present in the recombinant E.
- Another embodiemtn is a recombinant E. coli comprising: (a) a set of exogenous genes consisting of (i) at least one gene encoding a polypeptide having glycerol-3 -phosphate dehydrogenase activity; (ii) at least one gene encoding a polypeptide having glycerol-3 -phosphatase activity; and (iii) at least one subset of genes encoding the gene products o ⁇ dhaR, orfY, orfX, orfW, dhaBI, dhaB2, dhaB3 and orfZ, and (b) at least one endogenous gene encoding a non-specific catalytic activity to convert 3 -hydroxypropionaldehyde to 1,3-propanediol, wherein no functional dhaT gene encoding a 1 ,3-propanediol oxidoreductase activity is present in the recombinant E.
- This embodiment also includes a process using a recombinant E. coli further comprising a set of endogenous genes, each gene having a mutation inactivating the gene, the set consisting of: (a) a gene encoding a polypeptide having glycerol kinase activity; (b) a gene encoding a polypeptide having glycerol dehydrogenase activity; and (c) a gene encoding a polypeptide having triosephosphate isomerase activity.
- This embodiment still further includes a process for the bioproduction of 1,3-propanediol comprising: (a) contacting under suitable conditions the immediately disclosed recombinant E. coli with at least one carbon source selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and single-carbon substrates whereby 1,3-propanediol is produced; and (b) optionally recovering the 1 ,3-propanediol produced in (a). And also includes a further process for the bioproduction of
- 1,3-propanediol comprising: (a) contacting the recombinant E coli of the immediately disclosed embodiments that further comprise: (i) at least one exogenous gene encoding a polypeptide having a dehydratase activity; (ii) at least one exogenous gene encoding a dehydratase reactivation factor; (iii) at least one endogenous gene encoding a non-specific catalytic activity to convert 3 -hydroxypropionaldehyde to 1,3-propanediol, with at least one carbon source selected from the group consisting of glycerol and dihydroxyacetone, and (b) optionally recovering the 1,3-propanediol produced in (a).
- Figure 1 presents the gene organization within the sequence of the dha regulon subclone pHK28-26.
- Figure 2 presents a graph of the extracellular soluble protein (g/L) compared between two fermentations runs essentially as described in Example 7 using a constant feed of vitamin B 12 .
- the strain used was KLP23/pAH48/pKP32.
- dashed lines the strain used was KLP23/pAH48/pDT29.
- Figure 3 presents a graph of the cell viability [(viable cells/mL)/OD550] compared between two fermentations runs essentially as described in Example 7 using a constant feed of vitamin B j2 .
- the strain used was KLP23/pAH48/pKP32. In the other case (dashed lines), the strain used was KLP23/pAH48/pDT29.
- Figure 4 presents a graph of the yield of glycerol from glucose compared between two fermentations runs essentially as described in Example 7, but in the absence of vitamin B ⁇ 2 or coenzyme B ⁇ 2 .
- the strain used was KLP23/pAH48/pKP32.
- the strain used was KLP23/pAH48/pDT29.
- Figure 5 is a flow diagram illustrating the metabolic conversion of glucose to 1,3-propanediol.
- Figure 6 is a 2D-PAGE membrane blot with the soluble protein fraction extracted from a band showing endogenous E. coli oxidoreductase activity (non-specific catalytic activity) on a native gel.
- the 68 sequence descriptions and the sequence listing attached hereto will comply with the rules governing nucleotide and/or amino acid sequence disclosures in patent applications as set forth in 37 C.F.R.
- SEQ ID NO:l contains the nucleotide sequence determined from a 12.1 kb EcoRI-Sall fragment from pKPl (cosmid containing DNA from Klebsiella pneumoniae), subcloned into pIBI31 (IBI Biosystem, New Haven, CT), and termed pHK28-26. Table 1 further details genes, corresponding base pairs identified within SEQ ID NO:l, and associated functionality. See also Example 1.
- SEQ ID NO:57 contains the nucleotide sequence determined for yqhD.
- SEQ ID NO:58 contains the amino acid sequence determined for YahD.
- the deposit(s) will be maintained in the indicated international depository for at least 30 years and will be made available to the public upon the grant of a patent disclosing it.
- the availability of a deposit does not constitute a license to practice the subject invention in derogation of patent rights granted by government action.
- ATCC refers to the American Type Culture Collection international depository located 10801 University Boulevard., Manassas, VA 20110- 2209 U.S.A.
- ATCC No. is the accession number to cultures on deposit with the ATCC.
- DETAILED DESCRIPTION OF THE INVENTION The present invention provides for an improved process for bioconverting a fermentable carbon source directly to 1,3-propanediol using a single microorganism. The method is characterized by improved titer, yield, and cell viability as well as a decrease in cell lysis during fermentation.
- the present invention is based, in part, upon the observation that 1,3-propanediol fermentation processes comprising 1,3-propanediol oxidoreductase (dhaT) are characterized by high levels of 3 HP A and other aldehydes and ketones in the medium, which is correlated to a decrease in cell viability.
- the present invention is also based, in part, upon the unexpected finding that the model host, E. coli, is capable of converting 3-HPA to 1,3-propanediol by an endogenous non-specific catalytic activity capable of converting 3 -hydroxypropionaldehyde to 1,3-propanediol.
- the present invention is further based, in part, upon the unexpected finding that an E.
- coli fermentation process comprising this non-specific catalytic activity and lacking a functional dhaT results in increased cell viability during fermentation and provides for higher titers and/or yields of 1,3-propanediol than a fermentation process comprising a functional dhaT.
- glycerol is a model substrate
- the host microorganism has a mutation in wild-type dhaT such that there is no 1 ,3-propanediol oxidoreductase activity and comprises a non-specific catalytic activity sufficient to convert 3 -hydroxypropionaldehyde to 1,3-propanediol.
- glucose is a model substrate and recombinant E. coli is a model host.
- E. coli comprises an endogenous non-specific catalytic activity sufficient to convert 3 -hydroxypropionaldehyde to 1,3-propanediol.
- the nonspecific catalytic activity is an alcohol dehydrogenase.
- the present invention provides a recombinant E. coli expressing a group of genes comprising (a) at least one gene encoding a polypeptide having glycerol-3 -phosphate dehydrogenase activity; (b) at least one gene encoding a polypeptide having glycerol-3 -phosphatase activity; (c) at least one gene encoding a polypeptide having a dehydratase activity; (d) at least one gene encoding a dehydratase reactivation factor; and (e) at least one endogenous gene encoding an non-specific catalytic activity sufficient to convert 3 -hydroxypropionaldehyde to 1,3-propanediol; use of this microorganism converts glucose to 1 ,3-propanediol at a high titer.
- the elimination of the functional dhaT gene in this recombinant E. coli provides an unexpectedly higher tit
- the present invention provides an improved method for the biological production of 1,3-propanediol from a fermentable carbon source in a single microorganism.
- an improved process for the conversion of glucose to 1,3-propanediol is achieved by the use of a recombinant microorganism comprising a host E. coli transformed with the Klebsiella pneumomae dha regulon genes dhaR, orfY, dhaT, orfX, orfW, dhaBI, dhaB2, dhaB3, and orfZ, all these genes arranged in the same genetic organization as found in wild type Klebsiella pneumoniae.
- the titer obtained for the fermentation process is significantly higher than any titer previously reported for a similar fermentation. This improvement relies on the use of the plasmid pDT29 as described in Example 6 and Example 7.
- a further improved process for the production of 1 ,3-propanediol from glucose is achieved using a recombinant E. coli containing genes encoding a G3PDH, a G3P phosphtase, a dehydratase, and a dehydratase reactivation factor compared to a process using a recombinant E. coli containing genes encoding a G3PDH, a G3P phosphatase, a dehydratase, a dehydratase reactivation factor, and also a functional dhaT.
- the dramatically improved process relies on an endogenous gene encoding a non-specific catalytic activity, expected to be an alcohol dehydrogenase, which is present in E. coli.
- the dramatic improvement in the process is evident as an increase in 1,3-propanediol titer as illustrated in Examples 7 and 9.
- the improvement in the process is also evident as a decrease in cell lysis as determined by the extracellular soluble protein concentration in the fermentation broth.
- This aspect of the invention is illustrated in Figure 2.
- the improvement in the process is evident as prolonged cell viability over the course of the fermentation.
- This aspect of the invention is illustrated in Figure 3.
- the improvement in the process is also evident as an increase in yield.
- glycerol can be metabolized to a product other than 3-HPA.
- dhaT 1,3-propanediol oxidoreductase
- glycerol is not metabolized to a product other than 3-HPA. That this cryptic pathway is attributable to the presence or absence of a functional dhaT is demonstrated by the lower yield of glycerol from glucose as illustrated in Figure 4.
- the following terms may be used for interpretation of the claims and specification.
- G3PDH glycerol-3 -phosphate dehydrogenase
- DHAP dihydroxyacetone phosphate
- G3PDH glycerol-3-phosphate
- In vivo G3PDH may be NADH; NADPH; or FAD-dependent.
- NADH-dependent glycerol-3-phosphate dehydrogenase When specifically referring to a cofactor specific glycerol-3 -phosphate dehydrogenase, the terms "NADH-dependent glycerol-3-phosphate dehydrogenase", “NADPH-dependent glycerol-3 -phosphate dehydrogenase” and “FAD-dependent glycerol-3 -phosphate dehydrogenase” will be used.
- NADH-dependent and NADPH-dependent glycerol-3-phosphate dehydrogenases are able to use NADH and NADPH interchangeably (for example by the gene encoded by gpsA)
- NADH-dependent and NADPH-dependent glycerol-3-phosphate dehydrogenase will be used interchangeably.
- the NADH-dependent enzyme (EC 1.1.1.8) is encoded, for example, by several genes including GPDl (GenBank Z74071x2), or GPD2 (GenBank Z35169xl), or GPD3 (GenBank G984182), or DARl (GenBank Z74071x2).
- the NADPH-dependent enzyme (EC 1.1.1.94) is encoded by gpsA (GenBank U321643, (eds 197911-196892) G466746 and L45246).
- the FAD-dependent enzyme (EC 1.1.99.5) is encoded by GUT2 (GenBank Z47047x23), or glpD (GenBank G 147838), or glpABC (GenBank
- G3P phosphatase refers to a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol-3- phosphate and water to glycerol and inorganic phosphate.
- G3P phosphatase is encoded, for example, by GPP1 (GenBank Z47047xl25), or GPP2 (GenBank U18813xl 1) (see WO 9928480 and references therein, which are herein incorporated by reference).
- glycosyrene kinase refers to a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol and ATP to glycerol-3 - phosphate and ADP.
- the high-energy phosphate donor ATP may be replaced by physiological substitutes (e.g., phosphoenolpyruvate).
- Glycerol kinase is encoded, for example, by GUT1 (GenBank Ul 1583x19) and glpK (GenBank LI 9201) (see WO 9928480 and references therein, which are herein incorporated by reference).
- glycosyrene dehydrogenase refers to a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol to dihydroxyacetone (E.C. 1.1.1.6) or glycerol to glyceraldehyde (E.C. 1.1.1.72).
- a polypeptide responsible for an enzyme activity that catalyzes the conversion of glycerol to dihydroxyacetone is also referred to as a "dihydroxyacetone reductase”.
- Glycerol dehydrogenase may be dependent upon NADH (E.C. 1.1.1.6), NADPH (E.C. 1.1.1.72), or other cofactors (e.g., E.C. 1.1.99.22).
- a NADH-dependent glycerol dehydrogenase is encoded, for example, by gldA (GenBank U00006) (see WO 9928480 and references therein, which are herein incorporated by reference).
- the term "dehydratase enzyme” or “dehydratase” will refer to any enzyme activity that catalyzes the conversion of a glycerol molecule to the product 3-hydroxypropionaldehyde.
- the dehydratase enzymes include a glycerol dehydratase (E.C. 4.2.1.30) and a diol dehydratase (E.C.
- genes encoding the large or " ⁇ " subunit of glycerol dehydratase include dhaBI, gldA and dhaB; genes encoding the medium or " ⁇ " subunit include dhaB2, gldB, and dhaC; genes encoding the small or " ⁇ " subunit include dhaB3, gldC, and dhaE.
- genes encoding the large or " ⁇ " subunit of diol dehydratase include pduC and pddA; genes encoding the medium or " ⁇ " subunit include pduD and pddB; genes encoding the small or " ⁇ ” subunit include pduE and pddC.
- Glycerol and diol dehydratases are subject to mechanism-based suicide inactivation by glycerol and some other substrates (Daniel et al., FEMS Microbiol. Rev. 22, 553 (1999)).
- dehydratase reactivation factor refers to those proteins responsible for reactivating the dehydratase activity.
- dehydratase reactivating activity refers to the phenomenon of converting a dehydratase not capable of catalysis of a substrate to one capable of catalysis of a substrate or to the phenomenon of inhibiting the inactivation of a dehydratase or the phenomenon of extending the useful half-life of the dehydratase enzyme in vivo.
- Two proteins have been identified as being involved as the dehydratase reactivation factor (see WO 9821341 (US 6013494) and references therein, which are herein incorporated by reference; Daniel et al., supra; Toraya and Mori, J. Biol. Chem.
- genes encoding one of the proteins include orfZ, dhaB4, gdrA,pduG and ddrA. Also referring to Table 1 , genes encoding the second of the two proteins include orfX, or ⁇ b, gdrB, pduH and ddrB.
- 1,3-propanediol oxidoreductase refers to the polypeptide(s) responsible for an enzyme activity that is capable of catalyzing the interconversion of 3-HPA and 1,3-propanediol provided the gene(s) encoding such activity is found to be physically or transcriptionally linked to a dehydratase enzyme in its natural (i.e., wild type) setting; for example, the gene is found within a dh ⁇ regulon as is the case with dh ⁇ T from Klebsiella pneumonia.
- genes encoding a 1,3-propanediol oxidoreductase include dhaT from Klebsiella pneumoniae, Citrobacter freundii, and Clostridium pasteurianum. Each of these genes encode a polypeptide belonging to the family of type III alcohol dehydrogenases, exhibits a conserved iron-binding motif, and has a preference for the NAD + /NADH linked intercoversion of 3-HPA and 1,3-propanediol (Johnson and Lin, J. Bacteriol. 169, 2050 (1987); Daniel et al., J. Bacteriol. 177, 2151 (1995); and Leurs et al., FEMS Microbiol. Lett.
- dha regulon refers to a set of associated genes or open reading frames encoding various biological activities, including but not limited to a dehydratase activity, a reactivation activity, and a 1,3-propanediol oxidoreductase.
- a dha regulon comprises the open reading frames dhaR, orfY, dhaT, orfX, orfW, dhaBI, dhaB 2, dhaB3, and orfZ as described herein.
- non-specific catalytic activity refers to the polypeptide(s) responsible for an enzyme activity that is sufficient to catalyze the interconversion of 3-HPA and 1,3-propanediol and specifically excludes 1,3-propanediol oxidoreductase(s).
- these enzymes are alcohol dehydrogenases.
- Such enzymes may utilize cofactors other than NAD + /NADH, including but not limited to flavins such as FAD or FMN.
- a gene(s) for a non-specific alcohol dehydrogenase(s) is found, for example, to be endogenously encoded and functionally expressed within the microorganism E. coli KLP23.
- function refers to the catalytic activity of an enzyme in altering the energy required to perform a specific chemical reaction. It is understood that such an activity may apply to a reaction in equilibrium where the production of either product or substrate may be accomplished under suitable conditions.
- polypeptide and “protein” are used interchangeably.
- carbon substrate and “carbon source” refer to a carbon source capable of being metabolized by host microorganisms of the present invention and particularly carbon sources selected from the group consisting of monosaccharides, oligosaccharides, polysaccharides, and one-carbon substrates or mixtures thereof.
- host cell or “host microorganism” refer to a microorganism capable of receiving foreign or heterologous genes and of expressing those genes to produce an active gene product.
- foreign gene refers to genetic material native to one organism that has been placed within a host microorganism by various means.
- the gene of interest may be a naturally occurring gene, a mutated gene, or a synthetic gene.
- transformation and “transfection” refer to the acquisition of new genes in a cell after the incorporation of nucleic acid.
- the acquired genes may be integrated into chromosomal DNA or introduced as extrachromosomal replicating sequences.
- transformant refers to the product of a transformation.
- genetically altered refers to the process of changing hereditary material by transformation or mutation.
- recombinant microorganism and “transformed host” refer to any microorganism having been transformed with heterologous or foreign genes or extra copies of homologous genes.
- the recombinant microorganisms of the present invention express foreign genes encoding glycerol-3 -phosphate dehydrogenase (GPDl), glycerol-3 -phosphatase (GPP2), glycerol dehydratase (dhaBI, dhaB2 and dhaB3), dehydratase reactivation factor (orfZ and orfX), and optionally 1,3-propanediol oxidoreductase (dhaT) for the production of 1,3-propanediol from suitable carbon substrates.
- GPDl glycerol-3 -phosphate dehydrogenase
- GPP2 glycerol-3 -phosphatase
- dhaBI glycerol dehydratase
- a preferred embodiment is an E. coli transformed with these genes but lacking a functional dhaT.
- a host microorganism, other than E. coli may also be transformed to contain the disclosed genes and the gene for the non-specific catalytic activity for the interconversion of 3-HPA and 1,3-propanediol, specifically excluding 1,3- propanediol oxidoreductase(s) (dhaT).
- Gene refers to a nucleic acid fragment that expresses a specific protein, including regulatory sequences preceding (5' non-coding) and following (3' non- coding) the coding region.
- the terms "native” and "wild-type” refer to a gene as found in nature with its own regulatory sequences.
- encoding and coding refer to the process by which a gene, through the mechanisms of transcription and translation, produces an amino acid sequence. It is understood that the process of encoding a specific amino acid sequence includes DNA sequences that may involve base changes that do not cause a change in the encoded amino acid, or which involve base changes which may alter one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. It is therefore understood that the invention encompasses more than the specific exemplary sequences.
- isolated refers to a protein or DNA sequence that is removed from at least one component with which it is naturally associated.
- isolated nucleic acid molecule is a polymer of RNA or DNA that is single- or double-stranded, optionally containing synthetic, non-natural or altered nucleotide bases.
- An isolated nucleic acid molecule in the form of a polymer of DNA may be comprised of one or more segments of cDNA, genomic DNA or synthetic DNA.
- Substantially similar refers to nucleic acid molecules wherein changes in one or more nucleotide bases result in substitution of one or more amino acids, but do not affect the functional properties of the protein encoded by the DNA sequence. “Substantially similar” also refers to nucleic acid molecules wherein changes in one or more nucleotide bases do not affect the ability of the nucleic acid molecule to mediate alteration of gene expression by antisense or co-suppression technology.
- “Substantially similar” also refers to modifications of the nucleic acid molecules of the instant invention (such as deletion or insertion of one or more nucleotide bases) that do not substantially affect the functional properties of the resulting transcript vis-a-vis the ability to mediate alteration of gene expression by antisense or co-suppression technology or alteration of the functional properties of the resulting protein molecule.
- the invention encompasses more than the specific exemplary sequences. For example, it is well known in the art that alterations in a gene which result in the production of a chemically equivalent amino acid at a given site, but do not effect the functional properties of the encoded protein are common. For the purposes of the present invention substitutions are defined as exchanges within one of the following five groups: 1. Small aliphatic, nonpolar or slightly polar residues: Ala, Ser, Thr
- a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue (such as glycine) or a more hydrophobic residue (such as valine, leucine, or isoleucine).
- a codon encoding another less hydrophobic residue such as glycine
- a more hydrophobic residue such as valine, leucine, or isoleucine
- changes which result in substitution of one negatively charged residue for another such as aspartic acid for glutamic acid
- one positively charged residue for another such as lysine for arginine
- nucleotide changes which result in alteration of the N-terminal and C-terminal portions of the protein molecule would also not be expected to alter the activity of the protein.
- substantially similar sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65 °C and washed with 2X SSC, 0.1% SDS followed by 0.1 X SSC, 0.1% SDS), with the sequences exemplified herein.
- Preferred substantially similar nucleic acid fragments of the instant invention are those nucleic acid fragments whose DNA sequences are at least 80% identical to the DNA sequence of the nucleic acid fragments reported herein. More preferred nucleic acid fragments are at least 90% identical to the DNA sequence of the nucleic acid fragments reported herein. Most preferred are nucleic acid fragments that are at least 95% identical to the DNA sequence of the nucleic acid fragments reported herein.
- a nucleic acid fragment is "hybridizable" to another nucleic acid fragment, such as a cDNA, genomic DNA, or RNA, when a single stranded form of the nucleic acid fragment can anneal to the other nucleic acid fragment under the appropriate conditions of temperature and solution ionic strength.
- Hybridization and washing conditions are well known and exemplified in Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Second Edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor (1989), particularly Chapter 11 and Table 11.1 therein (entirely incorporated herein by reference).
- the conditions of temperature and ionic strength determine the "stringency" of the hybridization.
- low stringency hybridization conditions corresponding to a Tm of 55 °
- Moderate stringency hybridization conditions correspond to a higher Tm, e.g., 40% formamide, with 5X or 6X SSC.
- Hybridization requires that the two nucleic acids contain complementary sequences, although depending on the stringency of the hybridization, mismatches between bases are possible.
- the appropriate stringency for hybridizing nucleic acids depends on the length of the nucleic acids and the degree of complementation, variables well known in the art. The greater the degree of similarity or homology between two nucleotide sequences, the greater the value of Tm for hybrids of nucleic acids having those sequences.
- the relative stability (corresponding to higher Tm) of nucleic acid hybridization decreases in the following order: RNA:RNA, DNA:RNA, DNA:DNA.
- equations for calculating Tm have been derived (see Sambrook et al., supra, 9.50-9.51).
- the length for a hybridizable nucleic acid is at least about 10 nucleotides.
- a minimum length for a hybridizable nucleic acid is at least about 15 nucleotides; more preferably at least about 20 nucleotides; and most preferably the length is at least 30 nucleotides.
- the temperature and wash solution salt concentration may be adjusted as necessary according to factors such as length of the probe.
- a “substantial portion” refers to an amino acid or nucleotide sequence which comprises enough of the amino acid sequence of a polypeptide or the nucleotide sequence of a gene to afford putative identification of that polypeptide or gene, either by manual evaluation of the sequence by one skilled in the art, or by computer-automated sequence comparison and identification using algorithms such as BLAST (Basic Local Alignment Search Tool; Altschul et al., J. Mol. Biol. 215:403-410 (1993); see also www.ncbi.nlm.nih.gov/BLAST/).
- BLAST Basic Local Alignment Search Tool
- a sequence often or more contiguous amino acids or thirty or more nucleotides is necessary in order to putatively identify a polypeptide or nucleic acid sequence as homologous to a known protein or gene.
- gene-specific oligonucleotide probes comprising 20-30 contiguous nucleotides may be used in sequence-dependent methods of gene identification (e.g., Southern hybridization) and isolation (e.g., in situ hybridization of bacterial colonies or bacteriophage plaques).
- short oligonucleotides of 12-15 bases may be used as amplification primers in PCR in order to obtain a particular nucleic acid molecule comprising the primers.
- a "substantial portion" of a nucleotide sequence comprises enough of the sequence to afford specific identification and/or isolation of a nucleic acid molecule comprising the sequence.
- the instant specification teaches partial or complete amino acid and nucleotide sequences encoding one or more particular proteins.
- the skilled artisan, having the benefit of the sequences as reported herein, may now use all or a substantial portion of the disclosed sequences for the purpose known to those skilled in the art. Accordingly, the instant invention comprises the complete sequences as reported in the accompanying Sequence Listing, as well as substantial portions of those sequences as defined above.
- nucleotide bases that are capable to hybridizing to one another.
- adenosine is complementary to thymine
- cytosine is complementary to guanine.
- the instant invention also includes isolated nucleic acid molecules that are complementary to the complete sequences as reported in the accompanying Sequence Listing as well as those substantially similar nucleic acid sequences.
- identity is a relationship between two or more polypeptide sequences or two or more polynucleotide sequences, as determined by comparing the sequences.
- identity also means the degree of sequence relatedness between polypeptide or polynucleotide sequences, as the case may be, as determined by the match between strings of such sequences.
- Identity and similarity can be readily calculated by known methods, including but not limited to those described in: Computational Molecular Biology; Lesk, A. M., Ed.; Oxford University Press: New York, 1988; Biocomputing: Informatics and Genome Projects; Smith, D.
- the BLASTX program is publicly available from NCBI and other sources (BLAST Manual. Altschul et al., Natl. Cent. Biotechnol.
- gap penalty l 1
- the nucleotide sequence of the polynucleotide is identical to the reference sequence except that the polynucleotide sequence may include up to five point mutations per each 100 nucleotides of the reference nucleotide sequence.
- a polynucleotide having a nucleotide sequence at least 95% identical to a reference nucleotide sequence up to 5% of the nucleotides in the reference sequence may be deleted or substituted with another nucleotide, or a number of nucleotides up to 5% of the total nucleotides in the reference sequence may be inserted into the reference sequence.
- These mutations of the reference sequence may occur at the 5' or 3' terminal positions of the reference nucleotide sequence or anywhere between those terminal positions, interspersed either individually among nucleotides in the reference sequence or in one or more contiguous groups within the reference sequence.
- a polypeptide having an amino acid sequence having at least, for example, 95% identity to a reference amino acid sequence is intended that the amino acid sequence of the polypeptide is identical to the reference sequence except that the polypeptide sequence may include up to five amino acid alterations per each 100 amino acids of the reference amino acid.
- up to 5% of the amino acid residues in the reference sequence may be deleted or substituted with another amino acid, or a number of amino acids up to 5% of the total amino acid residues in the reference sequence may be inserted into the reference sequence.
- These alterations of the reference sequence may occur at the amino or carboxy terminal positions of the reference amino acid sequence or anywhere between those terminal positions, interspersed either individually among residues in the reference sequence or in one or more contiguous groups within the reference sequence.
- homologous refers to a protein or polypeptide native or naturally occurring in a given host cell.
- the invention includes microorganisms producing homologous proteins via recombinant DNA technology.
- percent homology refers to the extent of amino acid sequence identity between polypeptides. When a first amino acid sequence is identical to a second amino acid sequence, then the first and second amino acid sequences exhibit 100% homology.
- the homology between any two polypeptides is a direct function of the total number of matching amino acids at a given position in either sequence, e.g., if half of the total number of amino acids in either of the two sequences are the same then the two sequences are said to exhibit 50% homology.
- Codon degeneracy refers to divergence in the genetic code permitting variation of the nucleotide sequence without effecting the amino acid sequence of an encoded polypeptide. Accordingly, the instant invention relates to any nucleic acid molecule that encodes all or a substantial portion of the amino acid sequence as set forth in SEQ ID NO:57.
- the skilled artisan is well aware of the "codon- bias" exhibited by a specific host cell in usage of nucleotide codons to specify a given amino acid. Therefore, when synthesizing a gene for improved expression in a host cell, it is desirable to design the gene such that its frequency of codon usage approaches the frequency of preferred codon usage of the host cell.
- Modifications to the sequence such as deletions, insertions, or substitutions in the sequence which produce silent changes that do not substantially affect the functional properties of the resulting protein molecule are also contemplated.
- alteration in the gene sequence which reflect the degeneracy of the genetic code, or which result in the production of a chemically equivalent amino acid at a given site are contemplated.
- a codon for the amino acid alanine, a hydrophobic amino acid may be substituted by a codon encoding another less hydrophobic residue, such as glycine, or a more hydrophobic residue, such as valine, leucine, or isoleucine.
- sequences encompassed by this invention are also defined by their ability to hybridize, under stringent conditions (0.1X SSC, 0.1% SDS, 65 °C), with the sequences exemplified herein.
- expression refers to the transcription and translation to gene product from a gene coding for the sequence of the gene product.
- Plasmid refers to an extra chromosomal element often carrying genes which are not part of the central metabolism of the cell, and usually in the form of circular double-stranded DNA molecules.
- Such elements may be autonomously replicating sequences, genome integrating sequences, phage or nucleotide sequences, linear or circular, of a single- or double-stranded DNA or RNA, derived from any source, in which a number of nucleotide sequences have been joined or recombined into a unique construction which is capable of introducing a promoter fragment and DNA sequence for a selected gene product along with appropriate 3' untranslated sequence into a cell.
- Transformation cassette refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that facilitates transformation of a particular host cell.
- Expression cassette refers to a specific vector containing a foreign gene and having elements in addition to the foreign gene that allow for enhanced expression of that gene in a foreign host. Construction of Recombinant Organisms
- Recombinant organisms containing the necessary genes that will encode the enzymatic pathway for the conversion of a carbon substrate to 1,3-propanediol may be constructed using techniques well known in the art.
- Genes encoding glycerol-3 -phosphate dehydrogenase (GPDl), glycerol-3 -phosphatase (GPP2), glycerol dehydratase (dhaBI, dhaB2, and dhaB3), dehydratase reactivation factor (orfZ and orfX) and 1,3-propanediol oxidoreductase (dhaT) were isolated from a native host such as Klebsiella or Saccharomyces and used to transform host strains such as E. coli DH5 ⁇ , ⁇ CL707, AA200, or KLP23. Isolation of Genes
- PCR polymerase chain reaction
- cosmid libraries may be created where large segments of genomic DNA (35-45kb) may be packaged into vectors and used to transform appropriate hosts.
- Cosmid vectors are unique in being able to accommodate large quantities of DNA.
- cosmid vectors have at least one copy of the cos DNA sequence which is needed for packaging and subsequent circularization of the foreign DNA.
- these vectors will also contain an origin of replication such as ColEl and drug resistance markers such as a gene resistant to ampicillin or neomycin.
- cosmid vectors containing the linearized foreign DNA are then reacted with a DNA packaging vehicle such as bacteriophage. During the packaging process the cos sites are cleaved and the foreign DNA is packaged into the head portion of the bacterial viral particle. These particles are then used to transfect suitable host cells such as E. coli. Once injected into the cell, the foreign DNA circularizes under the influence of the cos sticky ends. In this manner large segments of foreign DNA can be introduced and expressed in recombinant host cells.
- Cosmid vectors and cosmid transformation methods were used within the context of the present invention to clone large segments of genomic DNA from bacterial genera known to possess genes capable of processing glycerol to 1,3-propanediol.
- genomic DNA from K. pneumoniae was isolated by methods well known in the art and digested with the restriction enzyme Sau3 A for insertion into a cosmid vector Supercos 1 and packaged using Gigapackll packaging extracts.
- E. coli XL 1 -Blue MR cells were transformed with the cosmid DNA. Transformants were screened for the ability to convert glycerol to 1,3-propanediol by growing the cells in the presence of glycerol and analyzing the media for 1 ,3-propanediol formation.
- dehydratase genes and dehydratase reactivation factor genes include, but are not limited to, Citrobacter, Clostridia and Salmonella (see Table 1 ). Genes Encoding G3PDH and G3P Phosphatase
- the present invention provides genes suitable for the expression of G3PDH and G3P phosphatase activities in a host cell.
- Genes encoding G3PDH are known.
- GPDl has been isolated from Saccharomyces and has the base sequence given by SEQ ID NO:53, encoding the amino acid sequence given in SEQ ID NO:54 (Wang et al., supra).
- G3PDH activity has also been isolated from Saccharomyces encoded by GPD2 (Eriksson et al., Mol. Microbiol. 17, 95 (1995)).
- any gene encoding a polypeptide responsible for NADH-dependent G3PDH activity is suitable wherein that activity is capable of catalyzing the conversion of dihydroxyacetone phosphate (DHAP) to glycerol-3-phosphate (G3P).
- DHAP dihydroxyacetone phosphate
- G3P glycerol-3-phosphate
- any gene encoding the amino acid sequence of NADH- dependent G3PDH's corresponding to the genes DARl, GPDl, GPD2, GPD3, and gpsA will be functional in the present invention wherein that amino acid sequence may encompass amino acid substitutions, deletions or additions that do not alter the function of the enzyme.
- G3PDH genes encoding G3PDH isolated from other sources will also be suitable for use in the present invention.
- Genes encoding G3P phosphatase are known.
- GPP2 has been isolated from Saccharomyces cerevisiae and has the base sequence given by SEQ ID NO:55, which encodes the amino acid sequence given in SEQ ID NO:56 (Norbeck et al., J Biol. Chem. 271, 13875 (1996)).
- any gene encoding a G3P phosphatase activity is suitable for use in the method wherein that activity is capable of catalyzing the conversion of glycerol-3 -phosphate plus H 2 O to glycerol plus inorganic phosphate.
- any gene encoding the amino acid sequence of G3P phosphatase corresponding to the genes GPP2 and GPP1 will be functional in the present invention including any amino acid sequence that encompasses amino acid substitutions, deletions or additions that do not alter the function of the G3P phosphatase enzyme.
- genes encoding G3P phosphatase isolated from other sources will also be suitable for use in the present invention.
- Suitable host cells for the recombinant production of 1,3-propanediol may be either prokaryotic or eukaryotic and will be limited only by the host cell ability to express the active enzymes for the 1,3-propanediol pathway.
- Suitable host cells will be bacteria such as Citrobacter, Enterobacter, Clostridium, Klebsiella, Aerobacter, Lactobacillus, Aspergillus, Saccharomyces, Schizosaccharomyces, Zygosaccharomyces, Pichia, Kluyveromyces, Candida, Hansenula, Debaryomyces, Mucor, Torulopsis, Methylobacter, Escherichia, Salmonella, Bacillus, Streptomyces, and Pseudomonas.
- Preferred in the present invention are E. coli, E. blattae, Klebsiella, Citrobacter, and Aerobacter.
- Microorganisms can be converted to a high titer 1,3-propanediol producer by using the following general protocol.
- the present invention provides a variety of vectors and transformation and expression cassettes suitable for the cloning, transformation and expression of G3PDH, G3P phosphatase, dehydratase, and dehydratase reactivation factor into a suitable host cell.
- Suitable vectors will be those which are compatible with the microorganism employed.
- Suitable vectors can be derived, for example, from a bacteria, a virus (such as bacteriophage T7 or a M-13 derived phage), a cosmid, a yeast or a plant. Protocols for obtaining and using such vectors are known to those in the art (Sambrook et al., Molecular Cloning: A Laboratory Manual - volumes 1, 2, 3 (Cold Spring Harbor Laboratory: Cold Spring Harbor, NY, 1989)).
- the vector or cassette contains sequences directing transcription and translation of the appropriate gene, a selectable marker, and sequences allowing autonomous replication or chromosomal integration.
- Suitable vectors comprise a region 5' of the gene, which harbors transcriptional initiation controls, and a region 3' of the DNA fragment which controls transcriptional termination. It is most preferred when both control regions are derived from genes homologous to the transformed host cell. Such control regions need not be derived from the genes native to the specific species chosen as a production host.
- Initiation control regions, or promoters, which are useful to drive expression of the G3PDH and G3P phosphatase genes (DARl and GPP2, respectively) in the desired host cell are numerous and familiar to those skilled in the art. Virtually any promoter capable of driving these genes is suitable for the present invention including but not limited to CYC 1 , HIS3 , GAL 1 , GAL 10, ADH1, PGK, PHO5, GAPDH, ADC1, TRP1, URA3, LEU2, ENO, and TPI (useful for expression in Saccharomyces); AOX1 (useful for expression in Pichia); and lac, tip, ⁇ P L , ⁇ P R , T7, tac, and trc (useful for expression in E. coli).
- Termination control regions may also be derived from various genes native to the preferred hosts. Optionally, a termination site may be unnecessary; however, it is most preferred if included.
- DNA encoding the enzymes are linked operably through initiation codons to selected expression control regions such that expression results in the formation of the appropriate messenger RNA.
- Particularly useful in the present invention are the vectors pDT29 and pKP32 which are designed to be used in conjunction with pAH48.
- the essential elements of pDT29 and pKP32 are derived from the dha regulon isolated from Klebsiella pneumoniae.
- pDT29 contains the open reading frames dhaR, orfY, dhaT, orfX, orfW, dhaBI, dhaB 2, and dhaB3, nucleotide the sequences of which are contained within S ⁇ Q ID NO: 1.
- pKP32 contains the same set of open reading frames as found on pDT29, from the same source, with the difference that pKP32 lacks the dhaT.
- pAH48 is the vehicle used for the introduction of DARl and GPP2 genes into the host cell and more specifically comprises the DARl and GPP2 genes isolated from Saccharomyces cerevisiae. Transformation of Suitable Hosts and Expression of Genes for the Production of 1.3-propanediol
- cassettes are used to transform appropriate host cells.
- Introduction of the cassette containing the genes encoding G3PDH, G3P phosphatase, dehydratase, and dehydratase reactivation factor into the host cell may be accomplished by known procedures such as by transformation (e.g., using calcium-permeabilized cells, electroporation), or by transfection using a recombinant phage virus (Sambrook et al., supra).
- cassettes were used to transform the E. coli as fully described in the GENERAL METHODS and EXAMPLES. Mutants
- the present method will be able to make use of cells having single or multiple mutations specifically designed to enhance the production of 1,3-propanediol.
- Cells that normally divert a carbon feed stock into non-productive pathways, or that exhibit significant catabolite repression could be mutated to avoid these phenotypic deficiencies.
- many wild type cells are subject to catabolite repression from glucose and by-products in the media and it is contemplated that mutant strains of these wild type organisms, capable of 1,3-propanediol production that are resistant to glucose repression, would be particularly useful in the present invention.
- UV radiation in this wavelength principally causes changes within nucleic acid sequence from guanidine and cytosine to adenine and thymidine. Since all cells have DNA repair mechanisms that would repair most UV induced mutations, agents such as caffeine and other inhibitors may be added to interrupt the repair process and maximize the number of effective mutations. Long wave UV mutations using light in the 300 nm to 400 nm range are also possible but are generally not as effective as the short wave UV light unless used in conjunction with various activators such as psoralen dyes that interact with the DNA.
- Mutagenesis with chemical agents is also effective for generating mutants and commonly used substances include chemicals that affect nonreplicating DNA such as HNO 2 and NH 2 OH, as well as agents that affect replicating DNA such as acridine dyes, notable for causing frameshift mutations.
- Specific methods for creating mutants using radiation or chemical agents are well documented in the art. See for example Thomas D. Brock in Biotechnology: A Textbook of Industrial Microbiology. Second Edition (1989) Sinauer Associates, Inc., Sunderland, MA., or Deshpande, Mukund V., Appl. Biochem. Biotechnol. 36, 227 (1992), herein incorporated by reference.
- mutants having the desired phenotype may be selected by a variety of methods. Random screening is most common where the mutagenized cells are selected for the ability to produce the desired product or intermediate. Alternatively, selective isolation of mutants can be performed by growing a mutagenized population on selective media where only resistant colonies can develop. Methods of mutant selection are highly developed and well known in the art of industrial microbiology. See for example Brock, Supra; DeMancilha et al., Food Chem. 14, 313 (1984). The elimination of an undesired enzyme activity may be also accomplished by disruption of the gene encoding the enzyme. Such methods are known to those skilled in the art and are exemplified in Example 4 and Example 8. Alterations in the 1.3-propanediol Production Pathway
- Glucose is converted in a series of steps by enzymes of the glycolytic pathway to dihydroxyacetone phosphate (DHAP) and 3-phospho- glyceraldehyde (3-PG).
- DHAP dihydroxyacetone phosphate
- 3-PG 3-phospho- glyceraldehyde
- Glycerol is then formed by either hydrolysis of DHAP to dihydroxyacetone (DHA) followed by reduction, or reduction of DHAP to glycerol 3-phosphate (G3P) followed by hydrolysis.
- DHA dihydroxyacetone
- G3P glycerol 3-phosphate
- the hydrolysis step can be catalyzed by any number of cellular phosphatases, which are known to be nonspecific with respect to their substrates, or the activity can be introduced into the host by recombination.
- the reduction step can be catalyzed by a NAD + (or NADP + ) linked host enzyme or the activity can be introduced into the host by recombination.
- NAD + or NADP +
- the dha regulon contains a glycerol dehydrogenase (E.C. 1.1.1.6) that catalyzes the reversible reaction of Equation 3.
- Glycerol is converted to 1,3-propanediol via the intermediate 3-hydroxy- propionaldehye (3-HPA) as has been described in detail above.
- the intermediate 3-HPA is produced from glycerol, Equation 1, by a dehydratase enzyme that can be encoded by the host or can be introduced into the host by recombination.
- This dehydratase can be glycerol dehydratase (E.C. 4.2.1.30), diol dehydratase
- 1,3-Propanediol is produced from 3-HPA, Equation 2, by a NAD + - (or NADP + ) linked host enzyme or the activity can be introduced into the host by recombination.
- This final reaction in the production of 1 ,3-propanediol can be catalyzed by 1,3-propanediol dehydrogenase (E.C. 1.1.1.202) or other alcohol dehydrogenases.
- Triosephosphate isomerase is the enzyme responsible for the conversion of DAHP to 3-phosphoglyceraldehyde, and as such allows the diversion of carbon flow from the main pathway form glucose to glycerol and 1,3-propanediol ( Figure 5).
- the deletion mutation (tpi-) enhances the overall metabolic efficiency of the desired pathway over that described in the art.
- 1,3-propanediol production pathway would also be useful to the present invention.
- the elimination of glycerol kinase prevents glycerol, formed from G3P by the action of G3P phosphatase, from being re-converted to G3P at the expense of ATP ( Figure 5).
- the elimination of glycerol dehydrogenase prevents glycerol, formed from DHAP by the action of NADH- dependent glycerol-3-phosphate dehydrogenase, from being converted to dihydroxyacetone (Figure 5).
- Mutations can be directed toward a structural gene so as to impair or improve the activity of an enzymatic activity or can be directed toward a regulatory gene, including promoter regions and ribosome binding sites, so as to modulate the expression level of an enzymatic activity.
- transformations and mutations can be combined so as to control particular enzyme activities for the enhancement of 1,3-propanediol production.
- the present invention utilizes a preferred pathway for the production of 1,3-propanediol from a sugar substrate where the carbon flow moves from glucose to DHAP, G3P, Glycerol, 3-HPA and finally to 1,3-propanediol.
- the present production strains have been engineered to maximize the metabolic efficiency of the pathway by incorporating various deletion mutations that prevent the diversion of carbon to non-productive compounds.
- Glycerol may be diverted from conversion to 3 HP A by transformation to either DHA or G3P via glycerol dehydrogenase or glycerol kinase as discussed above ( Figure 5). Accordingly, the present production strains contain deletion mutations in the gldA and glpK genes.
- DHAP may be diverted to 3-PG by triosephosphate isomerase, thus the present production microorganism also contains a deletion mutation in this gene.
- the present method additionally incorporates a dehydratase enzyme for the conversion of glycerol to 3 HP A, which functions in concert with the reactivation factor, encoded by orfX and orfZ of the dh ⁇ regulon ( Figure 5).
- a dehydratase enzyme for the conversion of glycerol to 3 HP A, which functions in concert with the reactivation factor, encoded by orfX and orfZ of the dh ⁇ regulon (Figure 5).
- conversion of the 3HPA to 1,3-propanediol is typically accomplished via a 1,3-propanediol oxidoreductase
- the present method utilizes a non-specific catalytic activity that produces greater titers and yields of the final product, 1,3-propanediol ( Figure 5). In such a
- an improved process for 1,3-propanediol production may utilize glycerol or dihydroxyacetone as a substrate where the pathway comprises only the last three substrates, glycerol -> 3HPA -» 1,3-propanediol.
- the oxidoreductase is again eliminated in favor of the non-specific catalytic activity, (expected to be an alcohol dehydrogenase), however the need for deletion mutations are nullified by the energy considerations of adding glycerol to the culture.
- titers of 1,3-propanediol of at least 71 g/L are achieved where titers of 200 g/L are expected.
- microorganisms which naturally contain all the elements of the dha regulon, may be manipulated so as to inactivate the dhaT gene encoding the 1 ,3-propandiol oxidoreductase activity.
- microorganisms will be expected to produce higher yields and titers of 1,3-propanediol, mediated by the presence of an endogenous catalytic activity, expected to be an alcohol dehydrogenase.
- examples of such microorganisms include but are not limited to Klebsiella sp. , Citrobacter sp. , and Clostridium sp. Media and Carbon Substrates
- Fermentation media in the present invention must contain suitable carbon substrates.
- suitable substrates may include but are not limited to monosaccharides such as glucose and fructose, oligosaccharides such as lactose or sucrose, polysaccharides such as starch or cellulose or mixtures thereof and unpurified mixtures from renewable feedstocks such as cheese whey permeate, cornsteep liquor, sugar beet molasses, and barley malt.
- the carbon substrate may also be one-carbon substrates such as carbon dioxide, or methanol for which metabolic conversion into key biochemical intermediates has been demonstrated. Glycerol production from single carbon sources (e.g., methanol, formaldehyde or formate) has been reported in methylotrophic yeasts (K.
- the ribulose monophosphate pathway involves the condensation of formate with ribulose-5-phosphate to form a 6-carbon sugar that becomes fructose and eventually the three-carbon product glyceraldehyde-3 -phosphate.
- the serine pathway assimilates the one-carbon compound into the glycolytic pathway via methylenetetrahydrofolate.
- methylotrophic microorganisms are also known to utilize a number of other carbon-containing compounds such as methylamine, glucosamine and a variety of amino acids for metabolic activity.
- methylotrophic yeast are known to utilize the carbon from methylamine to form trehalose or glycerol (Bellion et al., Microb. Growth Cl Compd, [Int. Symp.], 7th (1993), 415-32. Editor(s): Murrell, J. Collin; Kelly, Don P. Publisher: Intercept, Andover, UK).
- various species of Candida will metabolize alanine or oleic acid (Suiter et al., Arch. Microbiol. 153(5), 485-489 (1990)).
- the source of carbon utilized in the present invention may encompass a wide variety of carbon- containing substrates and will only be limited by the choice of microorganism or process.
- preferred carbon substrates are glucose, fructose, sucrose, or methanol where the process intends to produce an endogenous glycerol, and glycerol or dihydroxyacetone where the process anticipates a glycerol or dihydroxyacetone feed.
- fermentation media In addition to an appropriate carbon source, fermentation media must contain suitable minerals, salts, cofactors, buffers and other components, known to those skilled in the art, suitable for the growth of the cultures and promotion of the enzymatic pathway necessary for 1,3-propanediol production. Particular attention is given to Co(II) salts and/or vitamin B j or precursors thereof.
- Adenosyl-cobalamin (coenzyme B 12 ) is an essential cofactor for dehydratase activity. Synthesis of coenzyme B 12 is found in prokaryotes, some of which are able to synthesize the compound de novo, for example, Escherichia blattae, Klebsiella species, Citrobacter species, and Clostridium species, while others can perform partial reactions. E. coli, for example, cannot fabricate the corrin ring structure, but is able to catalyze the conversion of cobinamide to corrinoid and can introduce the 5'-deoxyadenosyl group.
- a coenzyme B 12 precursor such as vitamin Bj
- Vitamin B ⁇ 2 additions to E. coli fermentations may be added continuously, at a constant rate or staged as to coincide with the generation of cell mass, or may be added in single or multiple bolus additions.
- Preferred ratios of vitamin B j2 (mg) fed to cell mass (OD550) are from 0.06 to 0.60. Most preferred ratios of vitamin B 12 (mg) fed to cell mass (OD550) are from 0.12 to 0.48.
- vitamin Bj 2 is added to the transformed E. coli of the present invention it is contemplated that other microorganisms, capable of de novo B 12 biosynthesis will also be suitable production cells and the addition of B ⁇ 2 to these microorganisms will be unnecessary.
- Preferred growth media in the present invention are common commercially prepared media such as Luria Bertani (LB) broth, Sabouraud Dextrose (SD) broth or Yeast medium (YM) broth.
- LB Luria Bertani
- SD Sabouraud Dextrose
- YM Yeast medium
- Other defined or synthetic growth media may also be used and the appropriate medium for growth of the particular microorganism will be known by someone skilled in the art of microbiology or fermentation science.
- agents known to modulate catabolite repression directly or indirectly e.g., cyclic adenosine 2':3'-monophosphate, may also be incorporated into the reaction media.
- agents known to modulate enzymatic activities e.g., methyl viologen
- Suitable pH ranges for the fermentation are between pH 5.0 to pH 9.0, where pH 6.0 to pH 8.0 is preferred as the initial condition.
- Reactions may be performed under aerobic or anaerobic conditions where anaerobic or microaerobic conditions are preferred.
- Fed-batch fermentations may be performed with carbon feed, for example, glucose, limited or excess.
- carbon feed for example, glucose, limited or excess.
- the present process employs a batch method of fermentation.
- Classical batch fermentation is a closed system where the composition of the media is set at the beginning of the fermentation and is not subject to artificial alterations during the fermentation. Thus, at the beginning of the fermentation the media is inoculated with the desired microorganism or microorganisms and fermentation is permitted to occur adding nothing to the system.
- "batch" fermentation is batch with respect to the addition of carbon source and attempts are often made at controlling factors such as pH and oxygen concentration.
- the metabolite and biomass compositions of the system change constantly up to the time the fermentation is stopped.
- cells moderate through a static lag phase to a high growth log phase and finally to a stationary phase where growth rate is diminished or halted. If untreated, cells in the stationary phase will eventually die.
- Cells in log phase generally are responsible for the bulk of production of end product or intermediate.
- a variation on the standard batch system is the Fed-Batch system.
- Fed-Batch fermentation processes are also suitable in the present invention and comprise a typical batch system with the exception that the substrate is added in increments as the fermentation progresses.
- Fed-Batch systems are useful when catabolite repression is apt to inhibit the metabolism of the cells and where it is desirable to have limited amounts of substrate in the media. Measurement of the actual substrate concentration in Fed-Batch systems is difficult and is therefore estimated on the basis of the changes of measurable factors such as pH, dissolved oxygen and the partial pressure of waste gases such as CO 2 .
- Batch and Fed-Batch fermentations are common and well known in the art and examples may be found in Brock, supra.
- Continuous fermentation is an open system where a defined fermentation media is added continuously to a bioreactor and an equal amount of conditioned media is removed simultaneously for processing. Continuous fermentation generally maintains the cultures at a constant high density where cells are primarily in log phase growth.
- Continuous fermentation allows for the modulation of one factor or any number of factors that affect cell growth or end product concentration.
- one method will maintain a limiting nutrient such as the carbon source or nitrogen level at a fixed rate and allow all other parameters to moderate.
- a number of factors affecting growth can be altered continuously while the cell concentration, measured by media turbidity, is kept constant.
- Continuous systems strive to maintain steady state growth conditions and thus the cell loss due to media being drawn off must be balanced against the cell growth rate in the fermentation.
- the present invention may be practiced using batch, fed-batch or continuous processes and that any known mode of fermentation would be suitable. Additionally, it is contemplated that cells may be immobilized on a substrate as whole cell catalysts and subjected to fermentation conditions for 1,3-propanediol production. Identification and purification of 1,3-propanediol: Methods for the purification of 1 ,3-propanediol from fermentation media are known in the art. For example, propanediols can be obtained from cell media by subjecting the reaction mixture to extraction with an organic solvent, distillation, and column chromatography (U.S. 5,356,812). A particularly good organic solvent for this process is cyclohexane (U.S.
- 1 ,3-Propanediol may be identified directly by submitting the media to high pressure liquid chromatography (HPLC) analysis.
- HPLC high pressure liquid chromatography
- Preferred in the present invention is a method where fermentation media is analyzed on an analytical ion exchange column using a mobile phase of 0.0 IN sulfuric acid in an isocratic fashion.
- Dehydratase activity in cell-free extracts was determined using either glycerol or 1 ,2-propanediol as substrate.
- cell-free extracts were prepared by cell disruption using a french press followed by centrifugation of the cellular debris.
- the assay based on the reaction of aldehydes with methylbenzo-2-thiazolone hydrazone, has been described by Forage and Foster (Biochim. Biophys. Ada 569, 249 (1979)).
- 1,3-propanediol oxidoreductase sometimes referred to as 1,3-propanediol dehydrogenase
- 1,3-propanediol dehydrogenase The activity of 1,3-propanediol oxidoreductase, sometimes referred to as 1,3-propanediol dehydrogenase, was determined for cell-free extracts in solution or in slab gels using 1,3-propanediol and NAD + as substrates has been described (Johnson and Lin, J. Bacteriol. 169, 2050 (1987)).
- the conversion of 3-HPA and NADH to 1 ,3-propanediol and NAD + was determined by the disappearance of NADH.
- the slab gel assay has the potential advantage of separating the activity of 1,3-propanediol oxidoreductase (dhaT) from that of non-specific alcohol dehydrogenases by virtue of size separation.
- dhaT 1,3-propanediol oxidoreductases
- Citrobacter frendii, Klebsiella pneumoniae, and Clostridium pasteurianum are unusually large, on the order of 330,000 to 440,000 daltons.
- Lactobacillus brevis and Lactobacillus buchneri contain dehydratase associated 1,3-propanediol oxidoreductases with properties similar to those of known 1,3-propanediol oxidoreductases (dhaT).
- dhaT 1,3-propanediol oxidoreductases
- the assay for enzyme activity was performed by incubating the extract with an organic phosphate substrate in a bis-Tris or MES and magnesium buffer, pH 6.5.
- the substrate used was either 1- ⁇ -glycerol phosphate, or d,l- ⁇ -glycerol phosphate.
- the final concentrations of the reagents in the assay are: buffer (20 mM, bis-Tris or 50 mM MES); MgCl 2 (10 mM); and substrate (20 mM). If the total protein in the sample was low and no visible precipitation occurs with an acid quench, the sample was conveniently assayed in the cuvette.
- This method involved incubating an enzyme sample in a cuvette that contained 20 mM substrate (50 ⁇ L, 200 mM), 50 mM MES, 10 mM MgCl 2 , pH 6.5 buffer. The final phosphatase assay volume was 0.5 mL.
- the enzymatic reaction was quenched by the addition of the acid molybdate reagent (0.4 mL).
- NADH -linked glycerol dehydrogenase activity (gldA) in cell-free extracts from E. coli strains was determined after protein separation by non-denaturing polyacrylamide gel electrophoresis.
- the conversion of glycerol plus NAD + to dihydroxyacetone plus NADH was coupled with the conversion of 3-[4,5- dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT) to a deeply colored formazan, using phenazine methosulfate (PMS) as mediator (Tang et al., J Bacteriol 140, 182 (1997)).
- Electrophoresis was performed in duplicate by standard procedures using native gels (8-16% TG, 1.5 mm, 15 lane gels from Novex, San Diego, CA).
- Residual glycerol was removed from the gels by washing 3x with 50 mM Tris or potassium carbonate buffer, pH 9 for 10 min. The duplicate gels were developed, with and without glycerol (approximately 0.16 M final concentration), in 15 mL of assay solution containing 50 mM Tris or potassium carbonate, pH 9, 60 mg ammonium sulfate, 75 mg NAD + , 1.5 mg MTT, and 0.5 mg PMS.
- the retention times of glucose (RI detection), glycerol, 1,3-propanediol (RI detection), and trimethylacetic acid (UV and RI detection) were 15.27 min, 20.67 min, 26.08 min, and 35.03 min, respectively.
- An alternative method for GC/MS involved derivatization of the sample.
- sample e.g., culture supernatant
- 30 ⁇ L of concentrated (70% v/v) perchloric acid After mixing, the sample was frozen and lyophilized.
- a 1 :1 mixture of bis(trimethylsilyl)trifluoroacetamide:pyridine 300 ⁇ L was added to the lyophilized material, mixed vigorously and placed at 65 °C for one h.
- the sample was clarified of insoluble material by centrifugation.
- the resulting liquid partitioned into two phases, the upper of which was used for analysis.
- the sample was chromatographed on a DB-5 column (48 m, 0.25 mm I.D., 0.25 ⁇ m film thickness; from J&W Scientific) and the retention time and mass spectrum of the 1,3-propanediol derivative obtained from culture supernatants were compared to that obtained from authentic standards.
- the mass spectra of TMS-derivatized 1,3-propanediol contains the characteristic ions of 205, 177, 130 and 115 AMU.
- Cell lysis was estimated by measuring the extracellular soluble protein concentration in the fermentation broth. Fermenter samples were centrifuged in a desktop centrifuge (typically, 3-5 min at 12,000 rpm in an Eppendorf, Model 5415C micro centrifuge) in order to separate cells. The resulting supernatant was analyzed for protein concentration by the Bradford method using a commercially available reagent (Bio-Rad Protein Assay, Bio-Rad, Hercules, CA). Viability:
- Synthetic S12 medium was used in the screening of bacterial transformants for the ability to make 1,3-propanediol.
- S12 medium contains: 10 mM ammonium sulfate, 50 mM potassium phosphate buffer, pH 7.0, 2 mM MgCl 2 , 0.7 mM CaCl 2 , 50 ⁇ M MnCl 2 , 1 ⁇ M FeCl 3 , 1 ⁇ M ZnCl, 1.7 ⁇ M CuSO 4 , 2.5 ⁇ M CoCl 2 , 2.4 ⁇ M Na 2 MoO and 2 ⁇ M thiamine hydrochloride.
- Medium A used for growth and fermentation consisted of: 10 mM ammonium sulfate; 50 mM MOPS/KOH buffer, pH 7.5; 5 mM potassium phosphate buffer, pH 7.5; 2 mM MgCl 2 ; 0.7 mM CaCl 2 ; 50 ⁇ M MnCl 2 ; 1 ⁇ M FeCl 3 ; 1 ⁇ M ZnCl; 1.72 ⁇ M CuSO 4 ; 2.53 ⁇ M CoCl 2 ; 2.42 ⁇ M Na 2 MoO 4 ; 2 ⁇ M thiamine hydrochloride; 0.01% yeast extract; 0.01% casamino acids; 0.8 ⁇ g/mL vitamin B 12 ; and 50 ⁇ g/mL amp.
- Medium A was supplemented with either 0.2% glycerol or 0.2% glycerol plus 0.2% D-glucose as required.
- Cells was supplemented with either 0.2% glycerol or 0.2% glycerol plus 0.2% D-
- Klebsiella pneumoniae ECL2106 (Ruch et al., J. Bacteriol. 124, 348 (1975)), also known in the literature as K. aerogenes or Aerobacter aerogenes, was obtained from E. C. C. Lin (Harvard Medical School, Cambridge, MA) and was maintained as a laboratory culture.
- Klebsiella pneumoniae ATCC 25955 was purchased from American Type Culture Collection (Manassas, VA). E. coli DH5 was purchased from Gibco/BRL and was transformed with the cosmid DNA isolated from Klebsiella pneumoniae ATCC 25955 containing a gene coding for either a glycerol or diol dehydratase enzyme. Cosmids containing the glycerol dehydratase were identified as pKPl and pKP2 and cosmid containing the diol dehydratase enzyme were identified as pKP4. Transformed DH5 ⁇ cells were identified as DH5 ⁇ -pKPl, DH5 ⁇ -pKP2, and DH5 ⁇ -pKP4.
- E. coli ⁇ CL707 (Sprenger et al., J. Gen. Microbiol. 135, 1255 (1989)) was obtained from E. C. C. Lin (Harvard Medical School, Cambridge, MA) and was similarly transformed with cosmid DNA from Klebsiella pneumoniae. These transformants were identified as ECL707-pKPl and ECL707-pKP2, containing the glycerol dehydratase gene and ECL707-pKP4 containing the diol dehydratase gene.
- E. coli AA200 containing a mutation in the tpi gene was purchased from the E. coli Genetic Stock Center, Yale University (New Haven, CT) and was transformed with Klebsiella cosmid DNA to give the recombinant microorganisms AA200-pKPl and AA200-pKP2, containing the glycerol dehydratase gene, and AA200-pKP4, containing the diol dehydratase gene.
- DH5 ⁇ Six transformation plates containing approximately 1,000 colonies of
- E. coli XL 1 -Blue MR transfected with K. pneumoniae DNA were washed with 5 mL LB medium and centrifuged. The bacteria were pelleted and resuspended in 5 mL LB medium + glycerol. An aliquot (50 ⁇ L) was inoculated into a 15 mL tube containing S12 synthetic medium with 0.2% glycerol + 400 ng per mL of vitamin B ⁇ 2 + 0.001% yeast extract + 50 amp. The tube was filled with the medium to the top and wrapped with parafilm and incubated at 30 °C. A slight turbidity was observed after 48 h.
- a fragment of the open reading frame for dhaKl encoding dihydroxyacetone kinase is found at bases 1-399 (complement); the open reading frame dhaD encoding glycerol dehydrogenase is found at bases 1010-2107; the open reading frame dhaR encoding the repressor is found at bases 2209-4134; the open reading frame orfW, encoding a protein of unknown function is found at bases 4112-4642 (complement); the open reading frame orfK encoding a dehydratase reactivation protein is found at bases 4643-4996 (complement); the open reading frame dhaT encoding 1,3-propanediol oxidoreductase is found at bases 5017-6180 (complement); the open reading frame orfY, encoding a protein of unknown function is found at bases 6202-6630 (complement); the open reading frame dhaBI encoding the alpha subunit
- Single colonies of E. coli XL 1 -Blue MR transfected with packaged cosmid DNA from K pneumoniae were inoculated into microtiter wells containing 200 ⁇ L of S 15 medium (ammonium sulfate, 10 mM; potassium phosphate buffer, pH 7.0, 1 mM; MOPS/KOH buffer, pH 7.0, 50 mM; MgCl 2 , 2 mM; CaCl 2 , 0.7 mM; MnCl 2 , 50 ⁇ M; FeCl 3 , 1 ⁇ M; ZnCl, 1 ⁇ M; CuSO 4 , 1.72 ⁇ M; CoCl 2 , 2.53 ⁇ M; Na 2 MoO 4 , 2.42 ⁇ M; and thiamine hydrochloride, 2 ⁇ M) + 0.2% glycerol + 400 ng/mL of vitamin B ⁇ 2 + 0.001% yeast extract + 50 ⁇ g/mL ampicillin.
- S 15 medium ammonium sulfate
- a master plate containing LB-50 amp was also inoculated. After 96 h, 100 ⁇ L was withdrawn and centrifuged in a Rainin microfuge tube containing a 0.2 micron nylon membrane filter. Bacteria were retained and the filtrate was processed for HPLC analysis. Positive clones demonstrating 1,3-propanediol production were identified after screening approximately 240 colonies. Three positive clones were identified, two of which had grown on LB-50 amp and one of which had not. A single colony, isolated from one of the two positive clones grown on LB-50 amp and verified for the production of 1,3-propanediol, was designated as pKP4. Cosmid DNA was isolated from E.
- E. coli strains containing pKP4 and E. coli strain DH5 ⁇ was transformed.
- An independent transformant, designated as DH5 -pKP4, was verified for the production of 1,3-propanediol.
- ⁇ CL707 E. coli strain ECL707 was transformed with cosmid K pneumoniae DNA corresponding to one of pKPl, pKP2, pKP4 or the Supercos vector alone and named ECL707-pKPl, ECL707-pKP2, ECL707-pKP4, and ECL707-sc, respectively.
- ECL707 is defective in glpK, gld, and ptsD which encode the ATP-dependent glycerol kinase, NAD + -linked glycerol dehydrogenase, and enzyme II for dihydroxyacetone of the phosphoenolpyruvate-dependent phosphotransferase system, respectively.
- AA200 E. coli strain AA200 was transformed with cosmid K. pneumoniae DNA corresponding to one of pKPl, pKP2, pKP4 and the Supercos vector alone and named AA200-pKPl, AA200-pKP2, AA200-pKP4, and AA200-SC, respectively.
- Strain AA200 is defective in triosephosphate isomerase (tpi ⁇ ).
- E. coli FM5 (ATCC 53911) genomic DNA was prepared using the
- a 1.0 kb DNA fragment containing partial glpF and glycerol kinase (glpK) genes was amplified by PCR (Mullis and Faloona, Methods Enzymol 155, 335 (1987)) from FM5 genomic DNA using primers SEQ ID NO:2 and SEQ ID NO:3.
- a 1.1 kb DNA fragment containing partial glpK and glpX genes was amplified by PCR from
- this fragment had 1.0 kb and 1.1 kb flanking regions on either side of the Muni cloning site (within the partial glpK) to allow for chromosomal gene replacement by homologous recombination.
- the above 2.1 kb PCR fragment was blunt-ended (using mung bean nuclease) and cloned into the pCR-Blunt vector using the Zero Blunt PCR Cloning Kit (Invitrogen, San Diego, CA) to yield the 5.6 kb plasmid pRNlOO containing kanamycin and Zeocin resistance genes.
- the 1.2 kb Hindi fragment from pLoxCatl (unpublished results), containing a chloramphenicol-resistance gene flanked by bacteriophage PI loxP sites (Snaith et al., Gene 166, 173 (1995)), was used to interrupt the glpK fragment in plasmid pRNlOO by ligating it to wwl-digested (and blunt-ended) plasmid pRNlOO to yield the 6.9 kb plasmid pRNlOl-1.
- a 376 bp fragment containing the R6K origin was amplified by PCR from the vector pGP704 (Miller and Mekalanos, J.
- E. coli FM5 was electrotransformed with the non-replicative integration plasmid pRN 102-1 and transformants that were chloramphenicol-resistant (12.5 ⁇ g/mL) and kanamycin-sensitive (30 ⁇ g/mL) were further screened for glycerol non-utilization on M9 minimal medium containing 1 mM glycerol.
- An EcoRI digest of genomic DNA from one such mutant, RJFlOm when probed with the intact glpK gene via Southern analysis (Southern, J. Mol. Biol.
- mutant RJFlOm confirmed that it was incapable of converting 13 C-labeled glycerol and ATP to glycerol-3-phosphate.
- This glpK mutant was further analyzed by genomic PCR using primer combinations S ⁇ Q ID NO: 8 and S ⁇ Q ID NO:9, S ⁇ Q ID NO: 10 and S ⁇ Q ID NO:l 1, and S ⁇ Q ID NO:8 and S ⁇ Q ID NO: 11 which yielded the expected 2.3 kb, 2.4 kb, and 4.0 kb PCR fragments respectively.
- the wild-type control yielded the expected 3.5 kb band with primers S ⁇ Q ID NO:8 and S ⁇ Q ID NO:l 1.
- the glpK vXant RJFlOm was electrotransformed with plasmid pAH48 to allow glycerol production from glucose.
- the glpK mutant E. coli RJFlOm has been deposited with ATCC under the terms of the Budapest Treaty on 24 November 1997. Engineering of glycerol kinase mutant RJF10 with chloramphenicol resistance gene interrupt removed:
- E. coli RJFlOm in a water suspension was electrotransformed with plasmid pJW168 (unpublished results), which contained the bacteriophage PI Cre recombinase gene under the control of the IPTG- inducible / ⁇ cUV5 promoter, a temperature-sensitive pSClOl replicon, and an ampicillin resistance gene.
- plasmid pJW168 unpublished results
- transformants were selected at 30 °C (permissive temperature for pJW168 replication) on LB agar medium supplemented with carbenicillin (50 ⁇ g/mL) and IPTG (1 mM).
- glpK mutant RJF10
- genomic PCR primers SEQ ID NO: 8 and SEQ ID NO: 11 and yielded the expected 3.0 kb band confirming marker gene excision.
- Glycerol non- utilization by mutant RJF10 was confirmed by lack of growth on M9 minimal medium containing 1 mM glycerol.
- the glpK mutant RJF10 was electrotransformed with plasmid pAH48 to allow glycerol production from glucose.
- EXAMPLE 3 CONSTRUCTION OF E. COLI STRAIN WITH eldA GENE KNOCKOUT
- the gldA gene was isolated from E. coli by PCR (K. B. Mullis and F. A.
- E. coli FM5 was transformed with pMP33 and selected on 20 ⁇ g/mL kan at 30 °C, which is the permissive temperature for pMAK705 replication.
- glycerol dehydrogenase protein the product of gldA
- An activity assay was used to determine whether glycerol dehydrogenase activity remained in the transformants.
- Activity in glycerol dehydrogenase bands on native gels was determined by coupling the conversion of glycerol plus NAD + to dihydroxyacetone plus NADH to the conversion of a tetrazolium dye, MTT [3-(4,5-dimethylthiazol-2-yl)-2,5- diphenyltetrazolium bromide] to a deeply colored formazan, with phenazine methosulfate as mediator.
- Glycerol dehydrogenase also requires the presence of 30 mM ammonium sulfate and 100 mM Tris, pH 9 (Tang et al, J. Bacteriol 140, 182 (1997)). Of 8 transformants analyzed, 6 were determined to be gldA knockouts. E. coli MSP33.6 has been deposited with ATCC under the terms of the Budapest Treaty on 24 November 1997.
- a 1.6 kb DNA fragment containing the gldA gene and including 228 bps of DNA upstream of the translational start codon and 220 bps of DNA downstream of the translational stop codon was isolated from E. coli by PCR using primers SEQ ID NO: 18 and SEQ ID NO: 19, which incorporate terminal Sphl and Xbal sites, respectively, and cloned between the Sphl and Xbal sites of pUC18, to generate pQN2.
- pQN2 was cut at the unique Sail and Ncol sites within the gldA gene, the ends flushed with Klenow and religated, resulting in a 109 bps deletion in the middle of gldA and regeneration of a unique Sail site, to generate pQN4.
- a 1.2 kb DNA fragment containing the gene conferring kanamycin resistance (kan), and flanked by loxP sites was isolated from pLoxKan2 (Genencor International, Palo Alto, CA) as a Stul/Xhol fragment, the ends flushed with Klenow, and subcloned into pQN4 at the Sail site after flushing with Klenow, to generate pQN8.
- a 0.4 kb DNA fragment containing the R6K origin of replication was isolated from pGP704 (Miller and Mekalanos, J. Bacteriol 170, 2575-2583 (1988)) by PCR using primers SEQ ID NO:20 and SEQ ID NO:21, which incorporate terminal Sphl and Xbal sites, respectively, and ligated to the 2.8 kb Sphl/Xbal DNA fragment containing the gldA::kan cassette from pQN8, to generate pKP22.
- a 1.0 kb DNA fragment containing the gene conferring chloramphenicol resistance (cam), and flanked by loxP sites was isolated from pLoxCat2 (Genencor International, Palo Alto, CA) as an Xbal fragment, and subcloned into pKP22 at the Xbal site, to generate pKP23.
- E. coli strain RJFIO (see Example 2), which is glpK-, was transformed with pKP23 and transformants with the phenotype kanRcamS were isolated, indicating double crossover integration, which was confirmed by southern blot analysis.
- Glycerol dehydrogenase gel activity assays (as described in Example 3) demonstrated that active glycerol dehydrogenase was not present in these transformants.
- the kan marker was removed from the chromosome using the Cre-producing plasmid pJW168, as described in Example 2, to produce strain KLP23.
- Several isolates with the phenotype kanS demonstrated no glycerol dehydrogenase activity, and southern blot analysis confirmed loss of the kan marker.
- EXAMPLE 5 PLASMID CONSTRUCTION AND STRAIN CONSTRUCTION FOR THE EXPRESSION OF GLYCEROL 3-PHOSPHATE DEHYDROGENASE (DARl) AND/OR GLYCEROL 3-PHOSPHATASE (GPP2) Construction of expression cassettes for glycerol 3 -phosphatase (g ⁇ p2): The Saccharomyces cerevisiae chromosomeV lamda clone 6592 (GenBank, accession # UI 8813x11) was obtained from ATCC.
- the glycerol 3-phosphate phosphatase gene (GPP2) was cloned by cloning from the lamda clone as target DNA using synthetic primers (SEQ ID NO:22 with SEQ ID NO:23) incorporating an BamHI-RBS-Xbal site at the 5' end and a Smal site at the 3' end.
- the product was subcloned into pCR-Script (Stratagene, Madison, WI) at the Srfl site to generate the plasmid pAH15 containing GPP2.
- the plasmid pAH15 contains the GPP2 gene in the inactive orientation for expression from the lac promoter in pCR-Script SK+.
- the BamHI-Smal fragment from pAH15 containing the GPP2 gene was inserted into pBlueScriptll SK+ to generate plasmid pAH19.
- the pAH19 contains the GPP2 gene in the correct orientation for expression from the lac promoter.
- the Xbal-Pstl fragment from pAH19 containing the GPP2 gene was inserted into ⁇ PHOX2 to create plasmid pAH21.
- the pAH21/ DH5 ⁇ is the expression plasmid. Construction of expression cassettes for glycerol 3-phosphate dehydrogenase (DARl):
- DARl was isolated by PCR cloning from genomic S. cerevisiae DNA using synthetic primers (SEQ ID NO:24 with SEQ ID NO:25). Successful PCR cloning places an Ncol site at the 5' end of DARl where the ATG within Ncol is the DARl initiator methionine. At the 3' end of DARl a BamHI site is introduced following the translation terminator. The PCR fragments were digested with Ncol + BamHI and cloned into the same sites within the expression plasmid pTrc99A (Pharmacia, Piscataway, NJ) to give pDARl A.
- Plasmid pAH40 contains the new RBS and DARl gene in the correct orientation for expression from the trc promoter of pTrc99A (Pharmacia, Piscataway, NJ).
- the NcoI-BamHI fragment from pDARl A and an second set of Spel-RBS-NcoI linker obtained by annealing synthetic primers (SEQ ID NO:28 with SEQ ID NO:29) was inserted into the Spel-BamHI site of pBC-SK+ (Stratagene, Madison, WI) to create plasmid pAH42.
- the plasmid pAH42 contains a chloramphenicol resistant gene. Construction of expression cassettes for darl and gpp2:
- Expression cassettes for DARl and GPP2 were assembled from the individual DARl and GPP2 subclones described above using standard molecular biology methods.
- the BamHI-Pstl fragment from pAH19 containing the ribosomal binding site (RBS) and GPP2 gene was inserted into pAH40 to create pAH43.
- the BamHI-Pstl fragment from pAH19 containing the RBS and GPP2 gene was inserted into pAH42 to create pAH45.
- the ribosome binding site at the 5' end of GPP2 was modified as follows.
- a BamHI-RBS-Spel linker obtained by annealing synthetic primers GATCCAGGAAACAGA (SEQ ID NO:30) with CTAGTCTGTTTCCTG (SEQ ID NO:31) to the Xbal-Pstl fragment from pAH19 containing the GPP2 gene, was inserted into the BamHI-Pstl site of pAH40 to create pAH48.
- Plasmid pAH48 contains the DARl gene, the modified RBS, and the GPP2 gene in the correct orientation for expression from the trc promoter of pTrc99A (Pharmacia, Piscataway, NJ). Transformation of E. coli:
- the plasmids described here were transformed into E. coli DH5 ⁇ , FM5 and KLP23 using standard molecular biology techniques. The transformants were verified by their DNA RFLP pattern.
- the E. coli expression vector pTacIQ was prepared by inserting laclq gene (Farabaugh, Nature 274(5613), 765-769 (1978)) and tac promoter (Amann et al., Gene 25, 167-178 (1983)) into the restriction endonuclease site EcoRI of pBR322 (Sutcliffe, Cold Spring Harb. Symp. Quant. Biol 43, 77-90 (1979)).
- a multiple cloning site and terminator sequence replaces the pBR322 sequence from EcoRI to Sphl.
- Subcloning the glycerol dehydratase genes (dhaBI ,2,3, X):
- the open reading frame for the dhaB3 gene was amplified from pHK28-26 by PCR using primers (SEQ ID NO:33 and SEQ ID NO:34) incorporating an EcoRI site at the 5* end and a Xbal site at the 3' end.
- the product was subcloned into pLitmus29 (New England Biolab, Inc., Beverly, MA) to generate the plasmid pDHAB3 containing dhaB 3.
- the region containing the entire coding region for dhaBI, dhaBI, dhaB3 and dhaBX of the dhaB operon from pHK28-26 was cloned into pBluescriptIIKS+ (Stratagene, La Jolla, CA) using the restriction enzymes Kpnl and EcoRI to create the plasmid pM7.
- the dhaBX gene was removed by digesting plasmid pM7 with Apal and Xbal, purifying the 5.9 kb fragment and ligating it with the 325-bp Apal -Xbal fragment from plasmid pDHAB3 to create pMl 1 containing dhaBI, dhaB2 and dhaB3.
- the open reading frame for the dhaBI gene was amplified from pHK28-26 by PCR using primers (SEQ ID NO:35 and SEQ ID NO:36) incorporating a Hindlll site and a consensus ribosome binding site at the 5' end and a Xbal site at the 3' end.
- the product was subcloned into pLitmus28 (New England Biolab, Inc., Beverly, MA) to generate the plasmid pDTl containing dhaBI.
- a Notl-Xbal fragment from pMl 1 containing part of the dhaBI gene, the dhaB 2 gene and the dhaB 3 gene was inserted into pDTl to create the dhaB expression plasmid, pDT2.
- the Hindlll-Xbal fragment containing the dhaB (1,2, 3) genes from pDT2 was inserted into pTacIQ to create pDT3.
- the dhaT gene was amplified by PCR from pAHl as template DNA and synthetic primers (SEQ ID NO:37 with SEQ ID NO:38) incorporating an Xbal site at the 5' end and a BamHI site at the 3' end.
- the product was subcloned into pCR-Script (Stratagene) at the Srfl site to generate the plasmids pAH4 and pAH5 containing dhaT.
- the plasmid pAH4 contains the dhaT gene in the right orientation for expression from the lac promoter in pCR-Script and pAH5 contains dhaT gene in the opposite orientation.
- the Xbal-BamHI fragment from pAH4 containing the dhaT gene was inserted into pTacIQ to generate plasmid pAH8.
- the Hindll-BamHI fragment from pAH8 containing the RBS and dhaT gene was inserted into pBluescriptIIKS+ to create pAHl 1. Construction of an expression cassette for dhaT and dh ⁇ B( 1,2,3):
- An expression cassette for dh ⁇ T and dh ⁇ B(l,2,3) was assembled from the individual dh ⁇ B(l,2,3) and dh ⁇ T subclones described previously using standard molecular biology methods.
- a Spel-Sacl fragment containing the dh ⁇ B(l,2,3) genes from pDT3 was inserted into pAHl 1 at the Spel-Sacl sites to create pAH24.
- a Sall-Xbal linker (SEQ ID NO:39 and SEQ ID NO:40) was inserted into pAH5 that was digested with the restriction enzymes Sall-Xbal to create pDT16. The linker destroys the Xbal site.
- pDT21 was constructed by inserting the Sall-Notl fragment from pDTl 8 and the Notl-Xbal fragment from pM7 into pCL1920 (SEQ ID NO:41).
- the glucose isomerase promoter sequence from Streptomyces (SEQ ID NO:42) was cloned by PCR and inserted into EcoRI -HinDIII sites of pLitmus28 to construct pDT5.
- pCL1925 was constructed by inserting EcoRI-PvuII fragment of pDT5 into the EcoRI -Pvul site of pCL 1920.
- pDT24 was constructed by cloning the
- pDT21 was constructed by inserting the Sall-Notl fragment from pDT18 and the Notl-Xbal fragment from pM7 into pCL1920 (SEQ ID NO:41).
- the glucose isomerase promoter sequence from Streptomyces (SEQ ID NO:42) was cloned by PCR and inserted into EcoRI-HinDIII sites of pLitmus28 to construct pDT5.
- pCL1925 was constructed by inserting EcoRI-PvuII fragment of pDT5 into the EcoRI -Pvul site of pCL1920.
- pDT24 was constructed by cloning the HinDIII-MluII fragment of pDT21 and the Mlul-Xbal fragment of pDT21 into the HinDIII-Xbal sites of pCL1925.
- pDT29 was constructed by inserting the SacI-EcoRI fragment of pHK28-26 into SacI-EcoRI sites of pCL1925.
- a derivative of plasmid pDT29 was constructed in which all except the first 5 and the last 5 codons (plus stop codon) of the gene dh ⁇ T were deleted by a technique known as PCR-mediated overlap extension.
- SEQ ID NO:45 was paired with SEQ ID NO:46 to generate a product of 931 bps and encompassing nucleic acid including 5' dhaBI (to unique Seal site), all of orfY, and the first five codons of dhaT.
- SEQ ID NO:43 was paired with SEQ ID NO:44 to generate a product of 1348 bps and encompassing nucleic acid including the last five codons (plus stop codon) of dhaT, all of orfK, all of orfW, and 5' dhaR (to unique Sapl site).
- the 15 bases at the 5' end of SEQ ID NO:44 constitute a tail that is the inverse complement of a 15 base portion of SEQ ID NO:45.
- the 11 bases at the 5' end of SEQ ID NO:45 constitute a tail that is the inverse complement of an 11 base portion of SEQ ID NO:44.
- the 2 primary PCR products were joined together after annealing (via 26 bp tail overlap) and extending by PCR, to generate a third nucleic acid product of 2253 bps.
- This third PCR product was digested with Sapl and Seal and ligated into pDT29 which was also digested with Sapl and Seal, to generate the plasmid pKP32, which is identical to pDT29, except for the large, in-frame deletion within dhaT.
- KLP23/pAH48/pDT29 and KLP23/pAH48/pKP32 were pre-cultured for seeding a fermenter in 2YT medium (10 g/L yeast extract, 16 g/L tryptone, and 10 g/L NaCl) containing 200 mg/L carbenicillin (or ampicillin) and 50 mg/L spectinomycin.
- KLP23/pAH48/pKP32 is identical to KLP23/pAH48/pDT29 except that dhaT is deleted.
- the following components were sterilized together in the fermenter vessel: 45 g KH 2 PO 4 , 12 g citric acid, 12 g MgSO 4 -7H 2 O, 30 g yeast extract, 2.0 g ferric ammonium citrate, 5 mL Mazu DF204 as antifoam, 1.2 g CaCl 2 -2H O, and 7.3 mL sulfuric acid.
- the pH was raised to 6.8 with 20-28% NH 4 OH and the following components were added: 1.2 g carbenicillin or ampicillin, 0.30 g spectinomycin, 60 mL of a solution of trace elements and glucose (from a 60-67 weight % feed). After inoculation, the volume was 6.0 L and the glucose concentration was 10 g/L.
- the solution of trace elements contained (g/L): citric acid. H 2 O (4.0), MnSO 4 -H 2 O (3.0), NaCl (1.0), FeSO 4 -7H 2 O (0.10), CoCl 2 - 6H 2 O (0.10), ZnSO 4 -7H 2 O (0.10), CuSO 4 -5H 2 O (0.010), H 3 BO 3 (0.010), and Na 2 MoO 4 -2H 2 O (0.010). Fermentation growth:
- a 15 L stirred tank fermenter was prepared with the medium described above. The temperature was controlled at 35 °C and aqueous ammonia (20-28 weight %) was used to control pH at 6.8. Initial values for air flow rate (set to minimum values of between 6 and 12 standard liters per min) and agitator speed (set to minimum values of between 350 and 690 rpm) were set so that dissolved oxygen (DO) control was initiated when OUR values reached approximately 140 mmol/L/h. Back pressure was controlled at 0.5 bar. DO control was set at 10%. Except for minor excursions, glucose was maintained at between 0 g/L and 10 g/L with a 60% or 67% (wt) feed. Vitamin B 12 or coenzyme B 12 was added as noted below. Fermentation with KLP23/pAH48/pDT29:
- 1,3-propanediol (1,3-PD) using E. coli strain KLP23/pAH48/pKP32 is given in Table 5.
- Vitamin Bj 2 (0.150 g/L, 500 mL) was fed, starting 3 h after inoculation, at a rate of 16 mL/h. After 36 h, approximately 2 L of fermentation broth was purged in order to allow for the continued addition of glucose feed. The yield of 1 ,3-propanediol was 26 wt % (g 1 ,3-propanediol/g glucose consumed) and a titer of 112 g/L 1,3-propanediol was obtained.
- E. coli KLP23 genomic DNA was prepared using the Puregene DNA Isolation Kit (Gentra Systems, Minneapolis, MN). A 1.0 kb DNA fragment containing cdh and the 3' end of triosephosphate isomerase (tpiA) genes was amplified by PCR (Mullis and Faloona, Methods Enzymol. 155, 335-350 (1987)) from KLP23 genomic DNA using primers SEQ ID NO:47 and SEQ ID NO:48.
- a 1.0 kb DNA fragment containing the 5' end of tpiA, yiiQ, and the 5' end of yiiR genes was amplified by PCR from KLP23 genomic DNA using primers SEQ ID NO:49 and SEQ ID NO:50.
- a Seal site was incorporated into primer SEQ ID NO:49.
- the 5' end of primer SEQ ID NO:49 was the reverse complement of primer SEQ ID NO:48 to enable subsequent overlap extension PCR.
- the gene splicing by overlap extension technique was used to generate a 2.0 kb fragment by PCR using the above two PCR fragments as templates and primers SEQ ID NO:47 and SEQ ID NO:50.
- This fragment represented a deletion of 73% of the 768 bp tpiA structural gene. Overall, this fragment had 1.0 kb flanking regions on either side of the Seal cloning site (within the partial tpiA) to allow for chromosomal gene replacement by homologous recombination.
- the above blunt-ended 2.0 kb PCR fragment was cloned into the pCR-Blunt vector using the Zero Blunt PCR Cloning Kit (Invitrogen, San Diego, CA) to yield the 5.5 kb plasmid pRN 106-2 containing kanamycin and Zeocin resistance genes.
- E. coli KLP23 was electrotransformed with up to 1 ⁇ g of this 3.2 kb linear DNA fragment and transformants that were chloramphenicol-resistant (12.5 ⁇ g/mL) and kanamycin- sensitive (30 ⁇ g/mL) were further screened on M9 minimal media for poor glucose utilization on 1 mM glucose, for normal gluconate utilization on 1 mM gluconate, and to ensure the glycerol non-utilization phenotype of host KLP23 on 1 mM glycerol.
- This tpiA mutant was further analyzed by genomic PCR using primers SEQ ID NO:51 and SEQ ID NO:52, which yielded the expected 4.6 kb PCR fragment while for the same primer pair the host KLP23 and wild-type FM5 strains both yielded the expected 3.9 kb PCR fragment.
- SEQ ID NO:51 and SEQ ID NO:52 primers SEQ ID NO:51 and SEQ ID NO:52, which yielded the expected 4.6 kb PCR fragment while for the same primer pair the host KLP23 and wild-type FM5 strains both yielded the expected 3.9 kb PCR fragment.
- the tpiA mutant RJ8m was electrotransformed with plasmid pAH48 to allow glycerol production from glucose and also with both plasmids pAH48 and pDT29 or pKP32 to allow 1,3-propanediol production from glucose.
- the chloramphenicol resistance marker was eliminated from RJ8m to give RJ8.
- RJ8/pAH48/pDT29 and RJ8/pAH48/pKP32 were pre-cultured for seeding a fermenter as described in Example 7.
- RJ8/pAH48/pKP32 is identical to RJ8/pAH48/pDT29 except that dhaT is deleted.
- Fermenter medium :
- Fermenter medium was as described in Example 7. Fermentation growth:
- Fermenter growth was as described in Example 7 except that initial values for air flow rate (set to minimum values of between 5 and 6 standard liters per min) and agitator speed (set to minimum values of between 300 and 690 rpm) were set so that dissolved oxygen (DO) control was initiated when OUR values reached between 60 and 100 mmol/L/h. Vitamin B ⁇ 2 or coenzyme B 12 was added as noted below. Fermentation with RJ8/pAH48/pDT29:
- a representative fermentation summary of the conversion of glucose to 1,3-propanediol (1,3-PD) using E. coli strain RJ8/pAH48/pKP32 is given in Table 7.
- Vitamin B ⁇ 2 was provided as bolus additions of 48 and 16 mg at approximately 26 and 44 hr, respectively.
- the yield of 1,3-propanediol was 34 wt % (g 1,3-propanediol/g glucose consumed) and a titer of 129 g/L 1,3-propanediol was obtained.
- a whole cell assay for 1,3-propanediol dehydrogenase activity was used to demonstrate that the non-specific catalytic activity in E. coli is present under fermentative conditions after the addition of vitamin Bj and the production of 3- hydroxypropionaldehyde (3-HPA), but not before.
- a vitamin B ⁇ 2 bolus (48 mg) was added when the tanks reached approximately 100 OD550.
- a native gel activity stain assay was used to demonstrate non-specific catalytic activity in cell-free extracts.
- Cells were recovered, pre- and post-vitamin B ⁇ 2 addition, from representative 10-L fermentations employing recombinant
- E. coli strains containing the glycerol-production and 1,3-propanediol-production plasmids, pAH48 and pKP32, respectively; and cell-free extracts were prepared by cell disruption using a French press.
- the cell-free extracts, a preparation of pure Klebsiella pneumoniae 1,3-propanediol dehydrogenase (dhaT), and molecular weight standards were applied to and run out on native gradient polyacrylamide gels. The gels were then exposed to either the substrates 1,3-propanediol and NAD + or ethanol and NAD + .
- This native gel assay where proteins are separated by molecular weight prior to the enzymatic assay step, offered greater sensitivity and accuracy in measuring the reduction of 1,3-propanediol in those constructs with low activity and where the activity is likely to be distinct from the alcohol dehydrogenases with specificity towards ethanol as substrate that have been well characterized for E. coli and found in all organisms.
- the dehydrogenase assay works on the principle that dehydrogenase catalyzes the transfer of electrons from 1,3- propanediol (or other alcohols) to NAD + .
- PMS phenazine methosulfate
- MTT tetrazolium bromide dye
- the gels are washed to remove reagents and soluble dye.
- an insoluble blue dye forms.
- Various aspects of the assay have been described by Johnson and Lin (J. Bacteriol. 169:2050 (1987)). Purification and identification of the non-specific catalytic activity in E.
- a large scale, partial purification of non-specific catalytic activity was performed on cells harvested from the end of a typical 1,3-propanediol production run as described in the improved process using KLP23/pAH48/pKP32 of Example 7.
- the cell pellet (16 g) was washed and resuspended three times in 20 mL of 50 mM Hepes buffer, pH 7.5.
- the cells in the suspension were lysed by sonication.
- the cell-free extract was obtained by centrifugation (15 min, 20,000 x g, 10 °C) and the supernatant was further clarified by addition of 250 mg of protamine sulfate with stirring on ice.
- the supernatant obtained by centrifugation (20 min, 20,000 x g, 10 °C) was fractionated by passage through a Superdex® 200 preparative grade column (6 x 60 cm) equilibrated with Hepes buffer. Fractions of 10 mL each were collected and an aliquot of each was concentrated twenty five- fold using 10,000 MW cutoff Centricon® membranes prior to assay by the native gel activity stain. The non-specific catalytic activity was identified in fractions 107-112, and the peak activity in fractions 108-109. A larger aliquot (7 mL each) of fractions 108 and 109 were concentrated fifty-fold and loaded on all lanes of a 12-lane native gel.
- the gel was cut in half and one half was stained for dehydrogenase activity where a dark blue band appeared that represented the nonspecific catalytic activity.
- the unstained gel was aligned top to bottom with the stained gel and a band was cut on the unstained gel that corresponded to the band of non-specific catalytic activity.
- the gel strip was pulverized and soluble protein was extracted by immersing the pulverized particles in 0.5 mL of 2D-loading buffer, heating to 95 °C for 5 min, and centrifugation to remove the gel particles.
- the supernatant was loaded onto an isoelectricfocusing (IEF) strip for 2- dimension polyacrylamide gel electrophoresis (2D-PAGE) using conditions described for 2D-PAGE of E.
- IEF isoelectricfocusing
- Biochemical assays and amino-terminal amino acid sequencing suggested that non-specific catalytic activity may be encoded by the E. coli yqhD gene.
- This gene of unknown function encodes a hypothetical oxidoreductase and contains two alcohol dehydrogenase signatures also found in the Citrobacter freundii and Klebsiella pneumoniae 1,3-propanediol dehydrogenase encoded by the dhaT 'gene.
- yqhD and 830 bp of 5'-flanking DNA sequence and 906 bp of 3 '-flanking DNA sequence were amplified from E. coli KLP23 (Example 4) genomic DNA in a PCR using Taq polymerase and the following primers:
- Plasmid pJSP29 was digested with Aflll and Ndel to liberate a 409 bp DNA fragment comprising 363 bp of the yqhD gene and 46 bp of 3'-flanking DNA sequence.
- the remaining 5,350 bp DNA fragment was purified and ligated to the 1,374 bp AflHINdel DNA fragment containing the kanamycin resistance gene from pLoxKan2 (Genencor International, Palo Alto, CA) for 16 h at 16 °C.
- the ligated DNA was used to transform E. coli DH5 ⁇ and the expected plasmid, pJSP32-Blue, was isolated from a transformant selected on LB agar media containing kanamycin (50 ⁇ g/mL).
- Plasmid pJSP32-Blue was digested with Kpnl and Sacl and the 3,865 bp yqhD disruption cassette was purified and ligated to similarly digested pGP704 (Miller and Mekalanos, J. Bacteriol. 170:2575-2583 (1988)) for 16 h at 16 °C.
- the ligated DNA was used to transform E. coli SY327 (Miller and Mekalanos, J. Bacteriol. 170:2575-2583 (1988)) and the expected plasmid, pJSP32, was isolated from a transformant selected on LB agar media containing kanamycin (50 ⁇ g/mL). Plasmid pJSP32 was transformed into E.
- coli KLP23 and transformants were selected on LB agar containing kanamycin (50 ⁇ g/mL). Of the 200 kanamycin-resistant transformants screened, two demonstrated the ampicillin-sensitive phenotype expected for a double-crossover recombination event resulting in replacement of the yqhD gene with the yqhD disruption cassette.
- the yqhD disruption deletes the 3' end of yqhD, including 46 bp of 3 '-flanking intergenic DNA sequence.
- the deletion removes 363 bp of 3' yqhD coding sequence corresponding to 121 amino acids.
- a stop codon is present 15 bp downstream of the remaining yqhD coding sequence in the kanamycin resistance cassette.
- Plasmids pAH48 and pKP32 were co-transformed into E. coli KLP23 (yqhD ⁇ ) and transformants containing both plasmids were selected on LB agar containing ampicillin (100 ⁇ g/mL) and spectinomycin (50 ⁇ g/mL). A representative transformant was tested for its ability to covert glucose to 1,3- propanediol in 10 L fermentations either in the presence or absence of vitamin
- the highest titer of 1,3-propanediol obtained was 0.41 g/L.
- the organism was checked for its viability by plating a dilution series of the cells on agar plates containing ampicillin and spectinomycin. The plates were incubated for 24 h in a 30 °C incubator. There were no viable colonies on the plate from the fermentation of E. coli KLP23 0?/i£>-j/pAH48/pKP32, Table 11.
- the cell suspension from a control tank to which no vitamin B ⁇ 2 was added continued to accrue cell mass and glycerol until the 10-L tank was full due to the complete addition of the glucose feed solution (Table 10).
- An agar plate viability determination by dilution series of the cell suspension at the end of this fermentation showed a viable cell count that was consistent with the total cell number estimated by the optical density value (Table 11).
Abstract
Description
Claims
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CA2380616A CA2380616C (en) | 1999-08-18 | 2000-08-18 | Process for the biological production of 1,3-propanediol with high titer |
EP00955772A EP1204755B1 (en) | 1999-08-18 | 2000-08-18 | Process for the biological production of 1,3-propanediol |
DE60029971T DE60029971T2 (en) | 1999-08-18 | 2000-08-18 | PROCESS FOR THE BIOLOGICAL MANUFACTURE OF 1,3-PROPANEL |
BRPI0013315-9B1A BR0013315B1 (en) | 1999-08-18 | 2000-08-18 | Isolated nucleic acid fragment, polypeptide, chimeric gene, microorganism, recombinant microorganism, and recombinant coli, klp23 strain of e.g. recombinant coli, strain rj8 of e.g. recombinant coli, vector pdt29, vector pkp32 and 1,3-propanediol bioproduction processes |
BRPI0013315A BRPI0013315B8 (en) | 1999-08-18 | 2000-08-18 | isolated nucleic acid fragment, polypeptide, chimeric gene, microorganism, recombinant microorganism, e.g. recombinant coli, klp23 strain of e.g. recombinant coli, strain rj8 of e.g. recombinant coli, pdt29 vector, pkp32 vector and 1,3-propanediol bioproduction processes |
JP2001516920A JP4716634B2 (en) | 1999-08-18 | 2000-08-18 | Biological production of 1,3-propanediol with high titer |
HK02106363.4A HK1044963B (en) | 1999-08-18 | 2002-08-28 | Process for the biological production of 1,3-propanediol |
HK03103219A HK1051055A1 (en) | 1999-08-18 | 2003-05-06 | Process for the biological production of 1,3-propanediaol with high titer |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14953499P | 1999-08-18 | 1999-08-18 | |
US60/149,534 | 1999-08-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2001012833A2 true WO2001012833A2 (en) | 2001-02-22 |
WO2001012833A3 WO2001012833A3 (en) | 2001-08-30 |
Family
ID=22530731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2000/022874 WO2001012833A2 (en) | 1999-08-18 | 2000-08-18 | Process for the biological production of 1,3-propanediol |
Country Status (13)
Country | Link |
---|---|
US (5) | US6514733B1 (en) |
EP (1) | EP1204755B1 (en) |
JP (1) | JP4716634B2 (en) |
KR (1) | KR100785997B1 (en) |
CN (2) | CN101024843A (en) |
AT (1) | ATE335823T1 (en) |
BR (2) | BR0013315B1 (en) |
CA (2) | CA2380616C (en) |
DE (1) | DE60029971T2 (en) |
DK (1) | DK1204755T3 (en) |
HK (2) | HK1044963B (en) |
PT (1) | PT1204755E (en) |
WO (1) | WO2001012833A2 (en) |
Cited By (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002330763A (en) * | 2001-05-02 | 2002-11-19 | Ajinomoto Co Inc | Method for producing objective substance by fermentation |
WO2003089621A3 (en) * | 2002-04-22 | 2004-04-15 | Du Pont | Promoter and plasmid system for genetic engineering |
WO2004056963A2 (en) | 2002-12-16 | 2004-07-08 | E.I. Du Pont De Nemours And Company | B12 dependent dehydratases with improved reaction kinetics |
EP1576123A2 (en) * | 2002-10-04 | 2005-09-21 | E.I. du Pont de Nemours and Company | Process for the biological production of 1,3-propanediol with high yield |
WO2005093060A1 (en) * | 2004-03-26 | 2005-10-06 | Nippon Shokubai Co., Ltd. | Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid |
WO2005103262A1 (en) * | 2004-04-20 | 2005-11-03 | Cj Corp. | A novel diol dehydratase gene cluster in listeria genus |
US7033804B2 (en) | 2001-04-04 | 2006-04-25 | Genencor International, Inc. | Methods for the production of products in host cells |
US7241587B2 (en) | 2001-04-04 | 2007-07-10 | Genencor International, Inc. | Method of uncoupling the catabolic pathway of glycolysis from the oxidative membrane bound pathway of glucose conversion |
WO2008148640A1 (en) * | 2007-06-08 | 2008-12-11 | Evonik Degussa Gmbh | Microbiological production of aldehydes, especially of 3-hydroxypropionaldehyde |
US7524660B2 (en) | 2005-05-05 | 2009-04-28 | E.I. Du Pont De Nemours And Company | Utilization of fructose in microbial production strains |
WO2010076324A1 (en) | 2008-12-31 | 2010-07-08 | Metabolic Explorer | Method for the preparation of diols |
CN101130782B (en) * | 2007-07-23 | 2011-01-26 | 江南大学 | Construction method for producing 1,3-trimethylene glycol regrouping saccharomyces cerevisiae with glucose as substrate |
WO2011012697A2 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant yqhd enzyme for the production of a biochemical by fermentation |
US20110250610A1 (en) * | 2007-04-18 | 2011-10-13 | Butamax(Tm) Advanced Biofuels Llc | Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes |
EP2407544A1 (en) * | 2009-03-12 | 2012-01-18 | Korea Research Institute of Bioscience and Biotechnology | Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked |
US8389214B2 (en) | 2003-10-03 | 2013-03-05 | Danisco Us Inc. | Glucose transport mutants for production of biomaterial |
JP2013529924A (en) * | 2010-07-05 | 2013-07-25 | メタボリック エクスプローラー | Method for preparing 1,3-propanediol from sucrose |
WO2014009432A3 (en) * | 2012-07-11 | 2014-03-06 | Institut National Des Sciences Appliquées | A microorganism modified for the production of 1,3-propanediol |
US20140113342A1 (en) * | 2012-10-18 | 2014-04-24 | Algenol Biofuels Inc. | Production of 1,2-Propanediol in Cyanobacteria |
US8809059B2 (en) | 2007-09-21 | 2014-08-19 | Basf Plant Science Gmbh | Plants with increased yield |
US8852890B2 (en) | 2002-10-04 | 2014-10-07 | Danisco Us Inc. | Production of bacterial strains |
US9790521B2 (en) | 2011-03-24 | 2017-10-17 | Butamax Advanced Biofuels Llc | Host cells and methods for production of isobutanol |
US9932609B2 (en) | 2013-12-16 | 2018-04-03 | Gs Caltex Corporation | Recombinant microorganism having enhanced 1,3-propanediol producing ability and method for producing 1,3-propanediol using the same |
CN108085288A (en) * | 2017-12-22 | 2018-05-29 | 清华大学 | A kind of method using recombinant microorganism fermenting and producing 1,3- propylene glycol |
US10174345B2 (en) | 2012-09-26 | 2019-01-08 | Butamax Advanced Biofuels Llc | Polypeptides with ketol-acid reductoisomerase activity |
Families Citing this family (95)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1034278B1 (en) | 1997-12-02 | 2005-10-05 | E.I. Du Pont De Nemours And Company | Method for the production of glycerol by recombinant organisms |
KR100864672B1 (en) * | 2003-04-02 | 2008-10-23 | 씨제이제일제당 (주) | A method for producing a 1,2-propanediol using Klebsiella pneumoniae |
US7056439B2 (en) * | 2003-05-06 | 2006-06-06 | Tate & Lyle Ingredidents Americas, Inc. | Process for producing 1, 3-propanediol |
US7323539B2 (en) * | 2003-05-06 | 2008-01-29 | E. I. Du Pont De Nemours And Company | Polytrimethylene ether glycol and polytrimethylene ether ester with excellent quality |
FR2864967B1 (en) * | 2004-01-12 | 2006-05-19 | Metabolic Explorer Sa | ADVANCED MICROORGANISM FOR THE PRODUCTION OF 1,2-PROPANEDIOL |
US20070029252A1 (en) * | 2005-04-12 | 2007-02-08 | Dunson James B Jr | System and process for biomass treatment |
EP1869201B1 (en) * | 2005-04-12 | 2017-12-27 | E. I. du Pont de Nemours and Company | Integration of alternative feedstreams in biomass treatment and utilization |
US7781191B2 (en) * | 2005-04-12 | 2010-08-24 | E. I. Du Pont De Nemours And Company | Treatment of biomass to obtain a target chemical |
CN103183814B (en) | 2005-04-22 | 2016-03-02 | 三菱化学株式会社 | From polyester and the manufacture method thereof of biomass resource |
CN100427605C (en) * | 2005-06-17 | 2008-10-22 | 清华大学 | Mehtod for producing 1,3-propanediol and 2,3-cis-butanediol from crude starch material |
US9297028B2 (en) | 2005-09-29 | 2016-03-29 | Butamax Advanced Biofuels Llc | Fermentive production of four carbon alcohols |
US20080274526A1 (en) * | 2007-05-02 | 2008-11-06 | Bramucci Michael G | Method for the production of isobutanol |
US8945899B2 (en) | 2007-12-20 | 2015-02-03 | Butamax Advanced Biofuels Llc | Ketol-acid reductoisomerase using NADH |
US8956850B2 (en) * | 2008-06-05 | 2015-02-17 | Butamax Advanced Biofuels Llc | Enhanced pyruvate to acetolactate conversion in yeast |
EP1948814B1 (en) | 2005-10-26 | 2018-11-21 | Butamax (TM) Advanced Biofuels LLC | Fermentive production of four carbon alcohols |
CN100392071C (en) * | 2005-12-05 | 2008-06-04 | 中国农业大学 | Engineered bacterium lacking lactic acid production path and its construction method and uses |
US20070241306A1 (en) * | 2006-02-10 | 2007-10-18 | Ann Wehner | Biodegradable compositions comprising renewably-based, biodegradable 1,3-propanediol |
US20070275139A1 (en) * | 2006-02-10 | 2007-11-29 | Melissa Joerger | Food compositions comprising renewably-based, biodegradable1,3-propanediol |
US8828704B2 (en) | 2006-05-02 | 2014-09-09 | Butamax Advanced Biofuels Llc | Fermentive production of four carbon alcohols |
US8206970B2 (en) * | 2006-05-02 | 2012-06-26 | Butamax(Tm) Advanced Biofuels Llc | Production of 2-butanol and 2-butanone employing aminobutanol phosphate phospholyase |
US20080003653A1 (en) * | 2006-06-29 | 2008-01-03 | Wenzel J Douglas | Supplementation of ethanol fermentations and processes including supplemental components |
WO2008052596A1 (en) * | 2006-10-31 | 2008-05-08 | Metabolic Explorer | Process for the biological production of n-butanol with high yield |
JP2010508013A (en) * | 2006-10-31 | 2010-03-18 | メタボリック エクスプローラー | Method for biological production of 1,3-propanediol from glycerol in high yield |
US20080176957A1 (en) * | 2006-11-15 | 2008-07-24 | Dupont Tate & Lyle Bio Products Company, Llc | Preservative compositions comprising renewably-based, biodegradable 1,3-propanediol |
PL2137315T3 (en) | 2007-03-16 | 2015-02-27 | Genomatica Inc | Compositions and methods for the biosynthesis of 1,4-butanediol and its precursors |
US8426174B2 (en) * | 2007-05-02 | 2013-04-23 | Butamax(Tm) Advanced Biofuels Llc | Method for the production of 2-butanol |
US7947483B2 (en) | 2007-08-10 | 2011-05-24 | Genomatica, Inc. | Methods and organisms for the growth-coupled production of 1,4-butanediol |
US7807419B2 (en) * | 2007-08-22 | 2010-10-05 | E. I. Du Pont De Nemours And Company | Process for concentrated biomass saccharification |
US8445236B2 (en) * | 2007-08-22 | 2013-05-21 | Alliance For Sustainable Energy Llc | Biomass pretreatment |
US20090053800A1 (en) * | 2007-08-22 | 2009-02-26 | Julie Friend | Biomass Treatment Apparatus |
US7819976B2 (en) * | 2007-08-22 | 2010-10-26 | E. I. Du Pont De Nemours And Company | Biomass treatment method |
WO2010030711A2 (en) | 2008-09-10 | 2010-03-18 | Genomatica, Inc. | Microorganisms for the production of 1,4-butanediol |
AU2009296227A1 (en) * | 2008-09-29 | 2010-04-01 | Butamax(Tm) Advanced Biofuels Llc | Enhanced pyruvate to 2,3-butanediol conversion in lactic acid bacteria |
DE102009029567A1 (en) * | 2008-10-02 | 2010-04-08 | Basf Se | Process for depleting sulfur and / or sulfur-containing compounds from a biochemically produced organic compound |
CN101633928B (en) * | 2008-10-22 | 2011-09-14 | 大连理工大学 | Recombinant expression of aldehyde reductase and application thereof in bioconversion of glycerol into 1,3-propylene glycol |
WO2010064744A1 (en) * | 2008-12-03 | 2010-06-10 | Korea Research Institute Of Bioscience And Biotechnology | Mutant blocked in glycerol oxidaion pathway for producing 1,3-propanediol |
US20100159521A1 (en) * | 2008-12-19 | 2010-06-24 | E. I. Du Pont De Nemours And Company | Ozone treatment of biomass to enhance enzymatic saccharification |
KR101189187B1 (en) * | 2009-03-12 | 2012-10-10 | 한국생명공학연구원 | Method for Preparing 1,3-Propanediol Using Mutant Blocked in Glycerol Oxidation Pathway |
HUE031827T2 (en) * | 2009-06-04 | 2017-08-28 | Genomatica Inc | Process of separating components of a fermentation broth |
CN113528417A (en) | 2009-06-04 | 2021-10-22 | 基因组股份公司 | Microorganisms for producing 1, 4-butanediol and related methods |
KR101048485B1 (en) * | 2009-08-17 | 2011-07-12 | 부산대학교 산학협력단 | Method of culturing recombinant E. coli to simultaneously produce 3-hydroxypropionic acid and 1,3-propanediol from glycerol |
JP2013503647A (en) | 2009-09-09 | 2013-02-04 | ブラスケム ソシエダッド アノニマ | Microorganism and method for producing n-propanol |
CN105441374A (en) * | 2009-10-13 | 2016-03-30 | 基因组股份公司 | Microorganism for producing 1, 4-butanediol, 4-hydroxybutyraldehyde, 4-maloyl-COA, putrescine and related compound and related method thereof |
US8852903B2 (en) | 2009-10-23 | 2014-10-07 | E I Du Pont De Nemours And Company | Co-metabolism of fructose and glucose in microbial production strains |
CN102933715B (en) * | 2009-10-29 | 2015-04-29 | 韩国生命工学研究院 | Novel method for producing 3-hydroxypropionic acid from glycerol |
US8530210B2 (en) * | 2009-11-25 | 2013-09-10 | Genomatica, Inc. | Microorganisms and methods for the coproduction 1,4-butanediol and gamma-butyrolactone |
US20110136190A1 (en) | 2009-12-04 | 2011-06-09 | E. I. Du Pont De Nemours And Company | Recombinant bacteria for producing glycerol and glycerol-derived products from sucrose |
EP2534141B1 (en) | 2010-02-11 | 2016-04-20 | Metabolix, Inc. | Process for gamma-butyrolactone production |
US8637286B2 (en) | 2010-02-23 | 2014-01-28 | Genomatica, Inc. | Methods for increasing product yields |
US8048661B2 (en) | 2010-02-23 | 2011-11-01 | Genomatica, Inc. | Microbial organisms comprising exogenous nucleic acids encoding reductive TCA pathway enzymes |
US8721794B2 (en) | 2010-04-28 | 2014-05-13 | E I Du Pont De Nemours And Company | Production of high solids syrup from lignocellulosic biomass hydrolysate fermentation broth |
US8906235B2 (en) | 2010-04-28 | 2014-12-09 | E I Du Pont De Nemours And Company | Process for liquid/solid separation of lignocellulosic biomass hydrolysate fermentation broth |
KR101220499B1 (en) * | 2010-05-25 | 2013-01-10 | 한국생명공학연구원 | Method for Preparing 3-Hydroxypropionic Acid from Glycerol with High Yield |
US8651403B2 (en) | 2010-07-21 | 2014-02-18 | E I Du Pont De Nemours And Company | Anhydrous ammonia treatment for improved milling of biomass |
US20120125548A1 (en) | 2010-11-23 | 2012-05-24 | E. I. Du Pont De Nemours And Company | Continuously fed biomass pretreatment process for a packed bed reactor |
US20120125551A1 (en) | 2010-11-23 | 2012-05-24 | E. I. Du Pont De Nemours And Company | Biomass pretreatment process for a packed bed reactor |
US8129170B1 (en) | 2010-12-06 | 2012-03-06 | E.I. Du Pont De Nemours And Company | Recombinant bacteria having the ability to metabolize sucrose |
WO2012082720A2 (en) | 2010-12-13 | 2012-06-21 | Myriant Corporation | Method of producing succinic acid and other chemicals using sucrose-containing feedstock |
CA2830978C (en) | 2011-04-13 | 2016-01-05 | Elc Management Llc | Conditioning agents for personal care compositions |
CN103492542B (en) | 2011-04-13 | 2016-05-25 | Elc管理公司 | Be applicable to the mild anion surfactant of personal care composition |
WO2012170793A1 (en) | 2011-06-08 | 2012-12-13 | Metabolix, Inc. | Biorefinery process for thf production |
EP2540834A1 (en) * | 2011-06-29 | 2013-01-02 | Metabolic Explorer | Method for the preparation of 1,3-propanediol |
JP2013013353A (en) * | 2011-07-01 | 2013-01-24 | Daicel Corp | Method for producing 1,3-propanediol |
WO2013023140A1 (en) | 2011-08-10 | 2013-02-14 | Metabolix, Inc. | Post process purification for gamma-butyrolactone production |
JP2013070675A (en) * | 2011-09-28 | 2013-04-22 | Daicel Corp | Method for culturing recombinant bacterium producing alkyl diol |
US20160024532A1 (en) * | 2012-02-23 | 2016-01-28 | The Regents Of The University Of California | Atp driven direct photosynthetic production of fuels and chemicals |
US8686114B2 (en) | 2012-03-05 | 2014-04-01 | E I Du Pont De Nemours And Company | Variant sucrose transporter polypeptides |
US9017961B2 (en) | 2012-03-05 | 2015-04-28 | E.I. Du Pont De Nemours And Company | Recombinant bacteria comprising novel sucrose transporters |
CA2873109A1 (en) | 2012-05-11 | 2013-11-28 | Butamax Advanced Biofuels Llc | Ketol-acid reductoisomerase enzymes and methods of use |
BR112014030202A2 (en) | 2012-06-04 | 2017-09-12 | Genomatica Inc | microorganisms and methods for the production of 4-hydroxybutyrate 1,4-butanediol and related compounds |
WO2014062997A1 (en) * | 2012-10-18 | 2014-04-24 | Algenol Biofuels Inc. | Production of 1, 3-propanediol in cyanobacteria |
US9845474B2 (en) * | 2012-10-24 | 2017-12-19 | Calysta, Inc. | Engineering of multi-carbon substrate utilization pathways in methanotrophic bacteria |
US20140178954A1 (en) | 2012-12-20 | 2014-06-26 | E I Du Pont De Nemours And Company | Expression of xylose isomerase activity in yeast |
US8669076B1 (en) | 2013-03-11 | 2014-03-11 | E I Du Pont De Nemours And Company | Cow rumen xylose isomerases active in yeast cells |
US9187743B2 (en) | 2013-03-11 | 2015-11-17 | E I Du Pont De Nemours And Company | Bacterial xylose isomerases active in yeast cells |
US20140273105A1 (en) | 2013-03-12 | 2014-09-18 | E I Du Pont De Nemours And Company | Gradient pretreatment of lignocellulosic biomass |
US20140315258A1 (en) | 2013-03-14 | 2014-10-23 | Abengoa Bioenergy New Technologies, Llc | Methods for converting cellulosic waste to bioproducts |
KR102266181B1 (en) | 2013-09-03 | 2021-06-17 | 피티티 글로벌 케미컬 퍼블릭 컴퍼니 리미티드 | A process for manufacturing acrylic acid, acrylonitrile and 1,4-butanediol from 1,3-propanediol |
US10227623B2 (en) | 2013-11-24 | 2019-03-12 | E I Du Pont De Nemours And Company | High force and high stress destructuring of cellulosic biomass |
CN103789248B (en) * | 2014-02-14 | 2016-03-02 | 江苏大学 | The method of 1,3-PD is produced in a kind of 1,3-PD genetic engineering bacterium and conversion |
WO2016007350A1 (en) | 2014-07-09 | 2016-01-14 | Danisco Us Inc. | Preconditioning of lignocellulosic biomass |
CN104726505A (en) * | 2015-03-31 | 2015-06-24 | 上海交通大学 | Method for producing three-carbon compounds by using gene engineering cyanobacteria |
CN104774879B (en) * | 2015-04-29 | 2017-10-20 | 大连理工大学 | A kind of method of the propane diols of mixed fungus fermentation glycerol production 1,3 |
EP3330375A1 (en) | 2015-07-29 | 2018-06-06 | Abengoa Bioenergía Nuevas Tecnologías, S. A. | Expression of recombinant beta-xylosidase enzymes |
US9968531B2 (en) | 2015-08-05 | 2018-05-15 | Dupont Tate & Lyle Bio Products Company, Llc | Deodorants containing 1,3-propanediol |
BR112018070645A2 (en) | 2016-04-08 | 2019-02-05 | Du Pont | recombinant yeast cells, methods for producing a yeast cell and method for producing a target compound |
CN106906248A (en) * | 2017-03-28 | 2017-06-30 | 清华大学 | A kind of method of the propane diols of utilization recombinant microorganism fermenting and producing 1,3 |
CN107119003B (en) * | 2017-04-28 | 2020-04-24 | 中国科学院青岛生物能源与过程研究所 | Recombinant bacterium for synthesizing 3-hydroxypropionic acid by utilizing glucan and construction method and application thereof |
KR101994772B1 (en) * | 2017-11-09 | 2019-07-01 | 지에스칼텍스 주식회사 | New klebsiella pneumoniae strain for production of 1,3-propanediol from glucose and method for proding 1,3-propanediol using the same |
KR102053330B1 (en) | 2018-04-23 | 2019-12-06 | 한국과학기술연구원 | Composition for microorganism fermentation comprising glycerol and method for producing butyric acid using the same |
KR102201720B1 (en) * | 2018-05-24 | 2021-01-12 | 한화솔루션 주식회사 | Recombinant Corynebacterium Producing 1,3-PDO and Inhibited 3-HP Production and Method for Preparing 1,3-PDO Using Thereof |
CN109321610B (en) * | 2018-11-01 | 2022-11-04 | 上海交通大学 | Efficient preparation of 2-amino-1, 3-propanediol by microbial fermentation method |
CN110205277A (en) * | 2019-05-14 | 2019-09-06 | 河北科技师范学院 | The application of Salmonella enteritidis glpK gene delection |
CN111334459B (en) * | 2020-03-12 | 2022-11-25 | 中国科学院上海高等研究院 | Construction method and application of Klebsiella engineering bacteria for improving yield of 1, 3-propylene glycol |
CN114107145A (en) * | 2021-11-04 | 2022-03-01 | 清华大学 | Recombinant microorganism and application thereof in production of 1, 3-propylene glycol |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021339A1 (en) * | 1996-11-13 | 1998-05-22 | E.I. Du Pont De Nemours And Company | Method for the production of 1,3-propanediol by recombinant organisms |
WO1999028480A1 (en) * | 1997-12-02 | 1999-06-10 | E.I. Du Pont De Nemours And Company | Method for the production of glycerol by recombinant organisms |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3734764A1 (en) | 1987-10-14 | 1989-05-03 | Huels Chemische Werke Ag | Process for the preparation of 1,3-propanediol |
DE3878564T2 (en) | 1988-12-12 | 1993-08-19 | Unilever Nv | METHOD FOR THE MICROBIOLOGICAL PRODUCTION OF 1,3-PROPANDIOL FROM GLYCERIN. |
US5686276A (en) | 1995-05-12 | 1997-11-11 | E. I. Du Pont De Nemours And Company | Bioconversion of a fermentable carbon source to 1,3-propanediol by a single microorganism |
-
2000
- 2000-08-18 BR BRPI0013315-9B1A patent/BR0013315B1/en active IP Right Grant
- 2000-08-18 CN CNA2006101688404A patent/CN101024843A/en active Pending
- 2000-08-18 CA CA2380616A patent/CA2380616C/en not_active Expired - Lifetime
- 2000-08-18 BR BRPI0013315A patent/BRPI0013315B8/en not_active IP Right Cessation
- 2000-08-18 JP JP2001516920A patent/JP4716634B2/en not_active Expired - Lifetime
- 2000-08-18 CA CA2733616A patent/CA2733616C/en not_active Expired - Lifetime
- 2000-08-18 KR KR1020027002027A patent/KR100785997B1/en active IP Right Grant
- 2000-08-18 DE DE60029971T patent/DE60029971T2/en not_active Expired - Lifetime
- 2000-08-18 WO PCT/US2000/022874 patent/WO2001012833A2/en active IP Right Grant
- 2000-08-18 AT AT00955772T patent/ATE335823T1/en not_active IP Right Cessation
- 2000-08-18 DK DK00955772T patent/DK1204755T3/en active
- 2000-08-18 EP EP00955772A patent/EP1204755B1/en not_active Expired - Lifetime
- 2000-08-18 PT PT00955772T patent/PT1204755E/en unknown
- 2000-08-18 US US09/641,652 patent/US6514733B1/en not_active Expired - Lifetime
- 2000-08-18 CN CNB008144362A patent/CN1298852C/en not_active Expired - Lifetime
-
2002
- 2002-08-28 HK HK02106363.4A patent/HK1044963B/en not_active IP Right Cessation
- 2002-10-21 US US10/277,249 patent/US7067300B2/en not_active Expired - Lifetime
-
2003
- 2003-05-06 HK HK03103219A patent/HK1051055A1/en not_active IP Right Cessation
-
2006
- 2006-01-16 US US11/282,497 patent/US7504250B2/en not_active Expired - Fee Related
- 2006-02-13 US US11/282,993 patent/US7452710B2/en not_active Expired - Lifetime
-
2009
- 2009-02-16 US US12/371,745 patent/US20090253192A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998021339A1 (en) * | 1996-11-13 | 1998-05-22 | E.I. Du Pont De Nemours And Company | Method for the production of 1,3-propanediol by recombinant organisms |
WO1998021341A2 (en) * | 1996-11-13 | 1998-05-22 | Genencor International, Inc. | Method for the recombinant production of 1,3-propanediol |
WO1999028480A1 (en) * | 1997-12-02 | 1999-06-10 | E.I. Du Pont De Nemours And Company | Method for the production of glycerol by recombinant organisms |
Non-Patent Citations (3)
Title |
---|
BOUVET O M M ET AL: "Taxonomic diversity of anaerobic glycerol dissimilation in the Enterobacteriaceae." RESEARCH IN MICROBIOLOGY, vol. 146, no. 4, 1995, pages 279-290, XP000982719 ISSN: 0923-2508 * |
DATABASE EMBL [Online] Accession AE000383, 29 January 1997 (1997-01-29) BLATTNER F R ET AL: "Escherichia coli K-12 MG1655 section 273 of 400 of the complete genome." XP002162541 * |
SKRALY F A ET AL: "Construction and characterization of a 1,3-propanediol operon" APPLIED AND ENVIRONMENTAL MICROBIOLOGY,US,WASHINGTON,DC, vol. 64, no. 1, January 1998 (1998-01), pages 98-105, XP002134649 ISSN: 0099-2240 * |
Cited By (51)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2039774A1 (en) | 2001-04-04 | 2009-03-25 | Genencor International, Inc. | Methods for the production of products in host cells |
US7407780B2 (en) | 2001-04-04 | 2008-08-05 | Genencor International, Inc. | Process for producing glycerol in recombinant bacterial host cells |
US7241587B2 (en) | 2001-04-04 | 2007-07-10 | Genencor International, Inc. | Method of uncoupling the catabolic pathway of glycolysis from the oxidative membrane bound pathway of glucose conversion |
JP2010057499A (en) * | 2001-04-04 | 2010-03-18 | Genencor Internatl Inc | Uncoupled productive and catabolic pathway of host cell |
EP2055773A1 (en) | 2001-04-04 | 2009-05-06 | Genencor International, Inc. | Uncoupled productive and catabolic host cell pathways |
US7033804B2 (en) | 2001-04-04 | 2006-04-25 | Genencor International, Inc. | Methods for the production of products in host cells |
JP2002330763A (en) * | 2001-05-02 | 2002-11-19 | Ajinomoto Co Inc | Method for producing objective substance by fermentation |
US8497087B2 (en) | 2001-05-02 | 2013-07-30 | Ajinomoto Co., Inc. | Method for producing target substance by fermentation |
US8192959B2 (en) | 2002-04-22 | 2012-06-05 | Genencor International Inc | Promoter and plasmid system for genetic engineering |
US7510869B2 (en) | 2002-04-22 | 2009-03-31 | E.I. Du Pont De Nemours And Company | Promoter and plasmid system for genetic engineering |
US7132527B2 (en) | 2002-04-22 | 2006-11-07 | E. I. Du Pont De Nemours And Company | Promoter and plasmid system for genetic engineering |
EP2374879A2 (en) | 2002-04-22 | 2011-10-12 | E. I. du Pont de Nemours and Company | Promoter and plasmid system for genetic engineering |
CN100366730C (en) * | 2002-04-22 | 2008-02-06 | 纳幕尔杜邦公司 | Promoter and plasmid system for genetic engineering |
WO2003089621A3 (en) * | 2002-04-22 | 2004-04-15 | Du Pont | Promoter and plasmid system for genetic engineering |
EP1576123A4 (en) * | 2002-10-04 | 2007-09-12 | Du Pont | Process for the biological production of 1,3-propanediol with high yield |
US7371558B2 (en) | 2002-10-04 | 2008-05-13 | E.I. Du Pont De Nemours And Company | Process for the biological production of 1,3-propanediol with high yield |
US8852890B2 (en) | 2002-10-04 | 2014-10-07 | Danisco Us Inc. | Production of bacterial strains |
EP1576123A2 (en) * | 2002-10-04 | 2005-09-21 | E.I. du Pont de Nemours and Company | Process for the biological production of 1,3-propanediol with high yield |
AU2003287028B2 (en) * | 2002-10-04 | 2008-09-04 | E.I. Du Pont De Nemours And Company | Process for the biological production of 1,3-propanediol with high yield |
US7745184B2 (en) | 2002-10-04 | 2010-06-29 | E. I. Du Pont De Nemours And Co. | Process for the biological production of 1,3-propanediol with high yield |
EP1583818A2 (en) * | 2002-12-16 | 2005-10-12 | E.I. du Pont de Nemours and Company | B12 dependent dehydratases with improved reaction kinetics |
US7410754B1 (en) | 2002-12-16 | 2008-08-12 | E.I. Du Pont De Nemours And Company | B12 -dependent dehydratases with improved reaction kinetics |
US8569469B2 (en) | 2002-12-16 | 2013-10-29 | E I Du Pont De Nemours And Company | B12-dependent dehydratases with improved reaction kinetics |
US8445659B2 (en) | 2002-12-16 | 2013-05-21 | E I Du Pont De Nemours And Company | B12-dependent dehydratases with improved reaction kinetics |
WO2004056963A2 (en) | 2002-12-16 | 2004-07-08 | E.I. Du Pont De Nemours And Company | B12 dependent dehydratases with improved reaction kinetics |
US7985849B2 (en) | 2002-12-16 | 2011-07-26 | E. I. Du Pont De Nemours And Company | B12 dependent dehydratases with improved reaction kinetics |
EP1583818A4 (en) * | 2002-12-16 | 2007-08-15 | Du Pont | B12 dependent dehydratases with improved reaction kinetics |
US8389214B2 (en) | 2003-10-03 | 2013-03-05 | Danisco Us Inc. | Glucose transport mutants for production of biomaterial |
WO2005093060A1 (en) * | 2004-03-26 | 2005-10-06 | Nippon Shokubai Co., Ltd. | Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid |
EP1731604A1 (en) * | 2004-03-26 | 2006-12-13 | Nippon Shokubai Kagaku Kogyo Co. Ltd. | Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid |
EP1731604A4 (en) * | 2004-03-26 | 2007-04-04 | Nippon Catalytic Chem Ind | Process for producing 1,3-propanediol and/or 3-hydroxypropionic acid |
WO2005103262A1 (en) * | 2004-04-20 | 2005-11-03 | Cj Corp. | A novel diol dehydratase gene cluster in listeria genus |
US7524660B2 (en) | 2005-05-05 | 2009-04-28 | E.I. Du Pont De Nemours And Company | Utilization of fructose in microbial production strains |
US9284612B2 (en) * | 2007-04-18 | 2016-03-15 | Butamax Advanced Biofuels Llc | Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes |
US20110250610A1 (en) * | 2007-04-18 | 2011-10-13 | Butamax(Tm) Advanced Biofuels Llc | Fermentive production of isobutanol using highly active ketol-acid reductoisomerase enzymes |
WO2008148640A1 (en) * | 2007-06-08 | 2008-12-11 | Evonik Degussa Gmbh | Microbiological production of aldehydes, especially of 3-hydroxypropionaldehyde |
CN101130782B (en) * | 2007-07-23 | 2011-01-26 | 江南大学 | Construction method for producing 1,3-trimethylene glycol regrouping saccharomyces cerevisiae with glucose as substrate |
US8809059B2 (en) | 2007-09-21 | 2014-08-19 | Basf Plant Science Gmbh | Plants with increased yield |
US9121041B2 (en) | 2008-12-31 | 2015-09-01 | Metabolic Explorer | Method for the preparation of diols |
WO2010076324A1 (en) | 2008-12-31 | 2010-07-08 | Metabolic Explorer | Method for the preparation of diols |
EP2407544A4 (en) * | 2009-03-12 | 2014-01-22 | Korea Res Inst Of Bioscience | Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked |
EP2407544A1 (en) * | 2009-03-12 | 2012-01-18 | Korea Research Institute of Bioscience and Biotechnology | Production method for 1,3-propanediol using recombinant microbial strain having glycerol oxidation metabolic pathway blocked |
WO2011012697A2 (en) | 2009-07-30 | 2011-02-03 | Metabolic Explorer | Mutant yqhd enzyme for the production of a biochemical by fermentation |
JP2013529924A (en) * | 2010-07-05 | 2013-07-25 | メタボリック エクスプローラー | Method for preparing 1,3-propanediol from sucrose |
US9790521B2 (en) | 2011-03-24 | 2017-10-17 | Butamax Advanced Biofuels Llc | Host cells and methods for production of isobutanol |
US9605283B2 (en) | 2012-07-11 | 2017-03-28 | Institut National Des Sciences Appliquées | Microorganism modified for the production of 1,3-propanediol |
WO2014009432A3 (en) * | 2012-07-11 | 2014-03-06 | Institut National Des Sciences Appliquées | A microorganism modified for the production of 1,3-propanediol |
US10174345B2 (en) | 2012-09-26 | 2019-01-08 | Butamax Advanced Biofuels Llc | Polypeptides with ketol-acid reductoisomerase activity |
US20140113342A1 (en) * | 2012-10-18 | 2014-04-24 | Algenol Biofuels Inc. | Production of 1,2-Propanediol in Cyanobacteria |
US9932609B2 (en) | 2013-12-16 | 2018-04-03 | Gs Caltex Corporation | Recombinant microorganism having enhanced 1,3-propanediol producing ability and method for producing 1,3-propanediol using the same |
CN108085288A (en) * | 2017-12-22 | 2018-05-29 | 清华大学 | A kind of method using recombinant microorganism fermenting and producing 1,3- propylene glycol |
Also Published As
Publication number | Publication date |
---|---|
US20090253192A1 (en) | 2009-10-08 |
CN101024843A (en) | 2007-08-29 |
PT1204755E (en) | 2006-11-30 |
KR20020059364A (en) | 2002-07-12 |
JP4716634B2 (en) | 2011-07-06 |
DK1204755T3 (en) | 2006-12-11 |
CA2380616A1 (en) | 2001-02-22 |
WO2001012833A3 (en) | 2001-08-30 |
US20060121588A1 (en) | 2006-06-08 |
BRPI0013315B8 (en) | 2018-02-27 |
DE60029971T2 (en) | 2007-05-16 |
CN1379818A (en) | 2002-11-13 |
US20030157674A1 (en) | 2003-08-21 |
BR0013315A (en) | 2002-04-02 |
DE60029971D1 (en) | 2006-09-21 |
US20060148053A1 (en) | 2006-07-06 |
CA2380616C (en) | 2011-05-24 |
JP2003507022A (en) | 2003-02-25 |
EP1204755B1 (en) | 2006-08-09 |
US7067300B2 (en) | 2006-06-27 |
US7452710B2 (en) | 2008-11-18 |
BR0013315B1 (en) | 2013-06-25 |
CN1298852C (en) | 2007-02-07 |
HK1044963B (en) | 2007-01-19 |
HK1051055A1 (en) | 2003-07-18 |
EP1204755A2 (en) | 2002-05-15 |
ATE335823T1 (en) | 2006-09-15 |
CA2733616A1 (en) | 2001-02-22 |
US6514733B1 (en) | 2003-02-04 |
KR100785997B1 (en) | 2007-12-14 |
CA2733616C (en) | 2016-09-27 |
US7504250B2 (en) | 2009-03-17 |
HK1044963A1 (en) | 2002-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1204755B1 (en) | Process for the biological production of 1,3-propanediol | |
US7371558B2 (en) | Process for the biological production of 1,3-propanediol with high yield | |
US7005291B1 (en) | Transformed microorganisms and genes useful in the production of glycerol and 1,3-propanediol | |
EP1076708B1 (en) | Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport | |
US20060177915A1 (en) | Method for the production of glycerol by recombinant organisms | |
US7582457B2 (en) | Method for the production of 1,3-propanediol by recombinant organisms comprising genes for coenzyme B12 synthesis | |
EP1586647A1 (en) | Process for the biological production of 1,3-propanediol with high titer | |
MXPA02001712A (en) | Process for the biological production of 1,3-propanediol with high titer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): BR CA CN ID IN JP KR MX SG US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): BR CA CN ID IN JP KR MX SG US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: IN/PCT/2002/00040/MU Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2380616 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020027002027 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/2002/001712 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2000955772 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 008144362 Country of ref document: CN |
|
WWP | Wipo information: published in national office |
Ref document number: 2000955772 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020027002027 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 2000955772 Country of ref document: EP |